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In clinical trials, due to ethical considerations, adaptive designs are adopted as an
improvement to the standard 50-50 randomization. In a trial, a patient’s response
may be delayed for several stages or may not occur at all. However, due to the
scarcity of resources, it may be impossible to trace each patient’s response if it
is delayed for too long. Hence, we propose a model in which those responses
that are delayed for more than M stages are discarded, where M is some finite
constant defined for each trial. Under this setting, we have proved that the strong
consistency and asymptotics of both Yn and Nn still hold, where Yn is the urn
composition and Nn is the number of patients assigned to each treatment in n
trials. Some applications are also discussed. In addition, when there are missing
responses, we also establish the strong consistency and asymptotic normality of Yn
and Nn.
In the application of the Generalized Po´lya urn (GPU) model to adaptive de-
signs, the standard way is to use the urn models associated with a homogeneous
generating matrix. However, it is more reasonable to employ nonhomogeneous
generating matrices, especially when the patients’ responses show a time trend. In
the thesis, we propose a kind of design using nonconvergent generating matrices.
vi
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Explicitly, two alternating generating matrices, H1 and H2, are used. In this case,
the generating matrices do not converge, but have two different limiting points.
After thorough investigation, we can show that the urn composition will stabilize
as the number of patients increases. The convergence corresponds to the mean
of H1 and H2. Moreover, the asymptotic variance has the same order as in the
homogeneous case and asymptotic normality still holds. In addition, Monte-Carlo
simulation is carried out and the simulation results also support the theoretical
results. The possible reason for the convergence is also studied in the thesis.
Some of the research, such as Athreya and Karlin (1968) and Bai and Hu (1999),
studied the asymptotic properties of a linear combination or linear transformation
of Yn on ξi, where ξi is the right eigenvector of the generating matrix H with
respect to some eigenvalue, λi, except the maximal one. However, in both papers,
in the case that τ = 1/2, the calculation of the variance-covariance matrix of Ynξ
is too rough. In the thesis, we study the asymptotic properties of both Ynξ and
Nnξ and give the exact expression of the variance-covariance matrix for any value
of τ ≤ 1/2. Moreover, by studying the eigenstructure of the generating matrix
H, we present the reason why the elements in the variance-covariance matrix have





In pharmaceutical or medical research, clinical trials are designed to compare the
effectiveness of K different treatments, where K ≥ 2. In these trials, patients are
sequentially recruited and assigned to one of the K competing treatments based on
some allocation rules. Then the responses are recorded for evaluating the effects
of the treatments. The rules how to allocate different treatments to the patients
play important roles for the resulting data to contain the necessary information for
scientific purpose or for ethical reasons to have higher curing rates. The allocation
rule thus becomes a major focus in adaptive designs. Two of the most commonly
used designs are 50-50 randomization and adaptive randomization. When K = 2,
if 50-50 randomization is used, the patients are assigned to each treatment group
1
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with equal chance, i.e., probability 0.5. This design produces more informative
data for making inference about the treatment difference when the difference is
small and the cure rate is nearly constant (Yao and Wei 1996). When the effects of
treatments have significant differences, one may want to have more informative data
or higher cure rate from an ethical point of view. That is, since the patients become
available serially in time, with the progress of the trial, we accumulate information
about the treatments. When the accrued information favors one treatment over
the others, it is not ethical to still assign the patients to the inferior treatments as
if the difference does not exist. It is especially unethical when the experimental
objects are human beings and, sometimes, the outcome of the treatment is very
serious, such as death. Thus, adaptive design, as a data driving design, is adopted
to sequentially assign patients with a higher probability to the better treatment,
using the accumulating information about the treatment difference obtained in all
the previous stages.
In a clinical trial, if the patients are sequentially assigned to treatments in ac-
cordance with the outcomes at previous stages, such a design is said to be adaptive.
1.1.2 Motivation of Adaptive Designs
Since World War II, adaptive designs have gained increasing popularity in clinical
trials. The use of adaptive designs is to achieve the following two objectives at the
same time:
(i)For the benefit of the general population, to gain informative data for statistical
inferences;
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(ii)To provide the best possible medical care for each individual patient in the phase
of trial.
As a very convincing example, a clinical trial by Connor et al (1994) described
in Zelen and Wei (1995) motivated further studies. The aim of the trial was to
evaluate a new drug, AZT, which was used to reduce the risk of HIV transmission
from infected mothers to their infants. For each individual patient, Zelen and Wei
considered the endpoint to be whether or not the infant under study became HIV
infected.
In the process of the trial, the patients entered the study serially and were
assigned to either treatment immediately upon arrival. In the duration of the ex-
periment, there were totally 477 pregnant women enrolled in the trial. And they
were assigned to one of two treatment groups, called AZT group and placebo group.
In this trial, a 50-50 randomization scheme was employed, i.e. the patients were as-
signed to either group with equal probability, 0.5. Finally, there were 238 pregnant
women in the placebo group while 239 in the AZT group. At the conclusion of the
trial, there were 60 HIV infected infants in the placebo group among 238 new born
infants, while the corresponding number in the AZT group was only 20 among 239
newborns. The results show that there were three times as many infected infants
in the placebo group as those in the AZT group, which leads us to conjecture that
if more pregnant women had been assigned to the AZT group, more infants would
have been saved.
With the data obtained from the trial, Zelen and Wei (1995) simulated the trial
based on randomized play-the-winner rule (RPW, a kind of adaptive design which
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we will discuss in detail later). The simulation results showed that if a suitable
RPW rule were adopted, on the average, 300 and 177 patients would have been
assigned to AZT group and placebo group respectively. Moreover, based on the
simulation results, 30 infants were HIV-positive in the AZT group and another 30
were in the placebo group. In this way, compared to the 50-50 randomization, 20
more infants would have been saved. Moreover, it was shown that the use of RPW
would be as efficient as the 50-50 randomization for making inferences (Rosenberger
(1996)).
The results in this example lead most of us to think that if the RPW rule were
adopted, it is ethical to the patients in the trial phase.
In fact, since World War II, many researchers have realized the advantages
of adaptive designs and carried out studies on this topic. We briefly review the
existing literature in the following section.
1.2 Literature Review and Current Research
1.2.1 Historical Development of Adaptive Designs
In the early stages of the development of adaptive designs, Colton (1963) proposed
a simple risk function approach to design an optimal clinical trial when there are N
patients to be treated. In his paper, the risk only consisted of the consequence of
treating a patient with the inferior treatment. Then, fixed sample size and sequen-
tial trials were considered. To determine the optimal size of a fixed sample trial
and the optimal boundaries of a sequential trial, minimax, maximin and Bayesian
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approaches were used. Comparison of the different approaches, as well as that of
the results for the fixed and sequential plans, were made.
Later on, in Anscombe (1963), to test the difference between two treatments,
the use of the likelihood principle rather than the Neyman-Pearson theory was
suggested. The planning of the trial under an ethical imperative was discussed in
detail and the propriety was considered.
Zelen (1969) introduced the play-the-winner (PW) rule, which can achieve both
the ethical objective and the efficiency requirement for inference at the same time.
This rule can be simply described as: a success on a particular treatment generates
a future trial on the same treatment with the next patient, while a failure generates a
trial on the alternate treatment. In practice, the PW rule can be implemented with
an urn containing a ball of either Type A or Type B, which represents treatment
A or B, respectively. While the initial patient’s allocation is decided by tossing a
fair coin, at a later stage, when a patient comes into the trial, a ball is drawn from
the urn randomly without replacement and the patient is assigned to the treatment
according to the type of the ball obtained. When the response is observed, the urn
is adjusted based on the following rule: Whenever a success with treatment A or a
failure on treatment B is obtained, a ball of type A is added into the urn; while a
success with treatment B or a failure with A will generate one ball of type B. As
the composition of the urn changes, the relative frequency of the treatment A to
be assigned will deviate from 0.5 towards either 0 or 1 depending on if treatment
A is better than treatment B or not. The ratio of the expected number of patients






, where Ni is the
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number of patients receiving treatment i and qi = 1− pi with pi the probability of
success of treatment i, i = A,B. Consequently, the PW rule tends to assign more
patients to the treatment which performs better. Some analytical results on the
PW rule were given by Wang (1991b).
However, this design has a serious defect: when a new patient arrives, the
assignment to the patient may be stuck if the urn is empty, which happens when the
response of the previous patient is delayed. In this case, a remedy is to determine
the next assignment by tossing a fair coin. Thus, the patient will have equal
probability to be assigned to each treatment. Therefore, in a trial where the time
to observe the response is always longer than the duration between the arrival of
two consecutive patients, the urn is always empty. The process has to be paused,
or just return to the 50-50 allocation. In this case, the advantage of the PW rule is
limited compared to the standard 50-50 allocation scheme. Moreover, although this
rule tends to assign more patients to the better treatment, it is too deterministic
and may introduce selection bias into the trial.
Wei and Durham (1978) proposed the randomized play-the-winner (RPW) rule
as a modification of the PW rule. Similar to the PW rule, the RPW rule can be
realized with an urn containing two types of balls, A and B. Suppose, initially,
there are y0 balls of either type in the urn. At a stage, when a patient is available
for an assignment, a ball is drawn at random with replacement and the patient is
assigned to receive treatment i if a ball of type i is obtained, where i = A,B. When
the response occurs, we adjust the urn composition according to the following rule:
if the response is a success, we add additional β balls of type i and α balls of type j
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into the urn; otherwise, additional α balls of type i and β balls of type j are added,
where 0 ≤ α ≤ β; i, j = A,B and i 6= j. This rule is denoted as RPW(y0, α, β ).
It has been shown that this rule assigns more patients to the better treatment on
the average and it is applicable when responses are delayed. Moreover, the RPW
rule is not subject to selection bias.
In the decades following the publication of Wei and Durham (1978), adaptive
design drew much attention in the research field. The main results are summarized
as follows:
Some of the researchers concentrate on inferences based on the data obtained
from the trials. Wei (1988) described an exact permutation test based on some
real life data obtained from a trial using RPW rule. The aim of the trial is to test
the effectiveness of extracorporeal membrane oxygenation (ECMO), which is used
to treat some newborns with respiratory failure. The trial resulted in 11 successes
with all the patients in the experimental group and one failure with the only pa-
tient who was assigned to the control group. In the paper, an efficient algorithm is
provided to construct exact permutation tests for testing the equality of treatment
effects under RPW rule. Moreover, the procedure is illustrated with the ECMO
data. By studying the permutation distribution of the data under the RPW rule,
the one-sided p value is 0.051; however, if complete randomization is presumed, it
is 0.001. Thus, the author concluded that the degree of significance of the treat-
ment effect is exaggerated if the design is ignored in the analysis. Later on, using
the same dataset, from a frequentist point of view, Wei et al (1990) studied the
exact conditional, exact unconditional and approximate confidence interval for the
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treatment difference. Moreover, some comparisons between the performances of
conditional and unconditional method were shown. He concluded that, in the data
analysis, the design used for the trial should not be ignored and presumed com-
plete randomization. Begg (1990) discovered the reason of the serious discrepancies
between the two p values and pointed out the inappropriateness of small sample
sizes in important clinical trials. Another approach was to use the maximum like-
lihood estimator. Rosenberger and Sriram (1997) proved the strong consistency of
the maximum likelihood estimator of the probability of success for each treatment
and a law of iterated logarithm. Besides, they derived the exact Fisher’s infor-
mation matrix and constructed a fixed-size confidence region for a fully sequential
procedure.
Some research discusses the properties of the RPW rule when some of the
conditions are relaxed.
First, we must introduce the concept of delayed response.
If the outcomes of the previous patient may not be available before the arrival
of the next patient, the trials is said to have delayed response.
Eick (1988) introduced the multi-armed delayed response bandit with geomet-
ric discounting and present a computational method for calculating indices. On
the other hand, for this case, in Bai et al (2001), it is assumed that there exists
staggered entry of patients, which follows a general stochastic process with inde-
pendent and stationary increments. The time-to-response is assumed to follow a
general distribution which can depend on both the treatment allocation and the
response observed. The central limit theorem on Yn, the urn composition, for a
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very general set-up of adaptive designs with delayed responses is proved. The re-
sults in the paper indicate that although some of the responses do not occur at all,
the asymptotic properties still hold.
Motivated by Bai et al (2001), the first part of this thesis considers a type of
adaptive design when responses are delayed. In contrast to Bai’s model, the re-
sponses are ignored if they are delayed for too long, such as more than M stages,
which is intuitively reasonable. In this circumstance, we will show that the asymp-
totic normality holds. In addition, the order of the variance is the same as that in
the no-delay case.
In the second part of the thesis, I extend the model to include possible missing
data. Assuming that the delay and missing processes are both random and obey
certain distribution laws, I investigate the asymptotic properties of such adaptive
designs in chapter 3.
In Bandyopadhyay and Biswas (2000a), the assumption of dichotomous re-
sponse is relaxed. The response is assumed to be an ordinal variable with the pre-
treatment levels (x) 1, 2, . . . , k and posttreatment levels (y) 0, 1, . . . , k + 1, where
level 0 represents death and level k + 1 is cure. In the model, urn is also used as
the random mechanism for allocation. When a patient’s posttreatment response is
available, the urn is adjusted by adding (y − x + k)β balls of the same type and
(2k + 1− y)β balls of the opposite type, where β is some positive integer. In fact,
except for the dichotomous and polychotomous responses, continuous outcomes
are also very common, such as blood pressure. Rosenberger (1993) developed a
biased coin randomization scheme for continuous outcomes based on a linear rank
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statistic. The proposed statistic can test for treatment effect using a permutation
approach.
Based on the RPW rule, some new adaptive designs were proposed as modifi-
cations. Bandyopadhyay and Biswas (2000b) provided a unified approach to derive
a broad class of adaptive designs through a recursion relationship of the allocation
probabilities of the successive patients who arrive. From the relationship, a special
class of adaptive designs including the standard RPW rule can be obtained.
1.2.2 GPU Models and Existing Results
In adaptive designs, the so-called generalized Po´lya urn (GPU, which is also named
as Generalized Friedman Urn, GFU, in literature) model has been introduced for
randomization. We will briefly review the development of GPU and its application
to adaptive designs.
In fundamental probability theory, the Po´lya’s urn can be described as follows:
an urn initially contains Y0,1 white balls and Y0,2 red balls. At some stage, a ball
is drawn from the urn randomly with replacement. According to the outcome of
the draw, additional α balls of the same type of the drawn ball are added into the
urn. The next stage continues.
Friedman (1949) introduced a modified version of the Po´lya urn. In this urn
model, a ball is drawn randomly with replacement and α balls of the same type
of the drawn ball and β balls of the alternative type are added into the urn. This
model with the initial composition (Y0,1, Y0,2) is denoted by (Y0,1, Y0,2, α, β). Later,
Freedman (1965) proved the asymptotic properties of the urn composition for Fried-
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, where τ = (α− β)/(α + β), then
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n−τ (Yn,1 − Yn,2) a.s.→ W1,
where W1 is a random variable whose distribution is still unknown.
The GPU, as an extension of Friedman’s urn, can be characterized as follows:
An urn contains balls ofK types with initial compositionY0 = (Y0,1, Y0,2, . . . , Y0,K).
At the ith stage, a ball is drawn randomly with replacement. When the type k is
observed, k = 1, 2, . . . , K, the urn composition is adjusted based on the following
rule: dk,j(i) balls of type j are added into the urn, where j = 1, 2, . . . , K. The
adding rule can be represented with a matrix Di, where
Di =

d1,1(i) d1,2(i) · · · d1,K(i)
d2,1(i) d2,2(i) · · · d2,K(i)
· · · · · · · · · · · ·
dK,1(i) dK,2(i) · · · dK,K(i)

That is, the kth row of Di determines the adjustment made to the urn if the ball
drawn is of type k. This process continues until the nth stage completes.
In the adaptive design, the GPU can be used as the randomization mechanism
to assign the patients into different treatments. It has been widely studied in
literature. The application of the GPU to adaptive design is formulated as follows:
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Consider an urn which contains K types of balls, where K ≥ 2. Suppose at
the beginning of the trial, the number of balls in the urn is denoted as Y0 =
(Y0,1, Y0,2, . . . , Y0,K), where Y0,k is the number of the kth type of balls, where k =
1, 2, . . . , K. At the ith stage, where i = 1, 2, ..., n, when a patient comes into the
trial, a ball is randomly drawn from the urn with replacement. If the type of the
drawn ball is j, the patient is assigned to the corresponding treatment j. When
the outcome ηi is available, the urn composition is adjusted by the j-th row of a
matrix Di = (dj,l(ηi)), that is, dj,l(ηi) balls of the lth type are added to the urn,
where Di is a function of the response ηi to the treatment, j, l = 1, 2, . . .,K. The
procedure is repeated. After n stages, the urn composition is denoted by a vector
Yn = (Yn,1, Yn,2, . . . , Yn,K), where Yn,k represents the number of kth type balls in
the urn.
Here, Di is called the adding rule at the ith stage and Hi = E(Di|Fi−1) is
called the generating matrix, where Fi is the σ-field generated by Y0, Y1, . . . , Yi.
If Hi = H holds for all i = 1, 2, . . . , n, the model is called homogeneous; otherwise,
it is nonhomogeneous.
Athreya and Karlin (1967, 1968) embedded the process of the adaptive designs
into a branching process and presented the following asymptotic properties for the




where Nn,i is the total number of patients treated by treatment i in the n trials,
and vi is the ith element of the unit left eigenvector of H, the generating matrix,
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1. This result gives the limit of
Nn,i
n
, the allocation rate of patients assigned to the
treatment i, which is of great interest in sequential designs. In addition, they have




This indicates that, as the number of patients recruited increases, the urn com-
position will asymptotically be the same as patient allocation rates. In addition,
we know that as the number of trials increases, both the urn composition and the
proportion of patients in each treatment become stable.
The results in these two papers are of two-fold importance (Rosenberger 2002):
(i) it provides an extension of Friedman’s urn for K types of balls, where the number
of balls added to the urn at each stage can be random;
(ii) it provides a new technique for proving asymptotic properties of urn models, by
embedding the urn process in a continuous-time multitype Markov-chain branching
process.
The RPW rule we just discussed can also be implemented using the GPU.
Assume that there are two treatments, A and B, and response is dichotomous.
The urn composition is denoted by Yn = (Yn,A, Yn,B) with the initial composition
Y0 = (y0, y0). The adding rule is
Di =
 βηi + α(1− ηi) αηi + β(1− ηi)
αηi + β(1− ηi) βηi + α(1− ηi)
 ,
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where ηi = 1 or 0 according to the ith patient’s response to the treatment, which
is either a success or a failure.
Denote the generating matrix at the ith stage as Hi, according to the RPW
model, we know
Hi = H =
 βpA + αqA αpA + βqA
αpB + βqB βpB + αqB

where pj =Pr(success | treatment j), qj = 1 − pj, where j = A,B. Obviously,
the GPU is homogeneous in this model. There exists a unique maximal eigenvalue
with a left eigenvector V = (vA, vB), where vA, vB ≥ 0 and vA + vB = 1.
Then it can be shown that
Nn,A
n
a.s.→ vA = αpA + βqA
α(pA + pB) + β(qA + qB)
, (1.1)
where Nn,A is the number of patients assigned to treatment A in the first n trials.
Equation (1.1) gives the limiting value of the proportion of patients assigned to
treatment A in n trials.
From the standpoint of the individual patient in the trial, we would like the
proportion to be greater than 1/2 if treatment A is better than B, and less than
1/2, otherwise. Also, we hope that it deviates from 1/2 possibly according to the
magnitude of the difference of the treatment effects. Another point is, if we take
α = 0 and β = 1, the treatment allocation ratio,
Nn,A
Nn,B
, will tend to
qB
qA
; if pA = pB,
as n tends to infinity,
Nn,A
Nn,B
= 1/2, which is intuitively quite reasonable.
Another important result is
Yn,A
2µ+ n(α + β)
a.s.→ vA = αpA + βqA
α(pA + pB) + β(qA + qB)
, (1.2)
which determines the limiting point of the urn composition.
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Wei (1979) studied the property of adaptive design of K treatments, where
K ≥ 2, with Y0 = (y0, y0, . . . , y0) and the adding rules given by
Di =

αηi β(1− ηi) · · · · · · β(1− ηi)
β(1− ηi) αηi · · · · · · β(1− ηi)
· · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · · ·
β(1− ηi) β(1− ηi) · · · · · · αηi

,
where ηi = 1 or 0 according to the ith patient’s response to the treatment, which
is either a success or a failure.




αp1 βq1 · · · βq1
βq2 αp2 · · · βq2
· · · · · · · · · · · ·
· · · · · · · · · · · ·
βqK βqK · · · αpK

,
where pj = 1−qj is the probability of success of the jth treatment, i.e. pj = P (ηi =
1|treatment j), where i = 1, 2, . . . , n, j = 1, 2, . . . , K.
This model is denoted by GPUD(Y0, α, β). Usually, α takes on value 1 and
β =
1
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where Nn = (Nn,1, Nn,2, . . . , Nn,K), Nn,j is the number of patients treated by treat-
ment j in the n trials and V = (v1, v2, . . . , vK) is the left eigenvector of H cor-
responding to the maximal eigenvalue 1 with the restraint that
K∑
i=1
vi = 1 and
vi > 0.
However, in these models, it seems to be counterintuitive to add balls of other
types when a failure occurs, because it gives no information about the effectiveness
of the other K − 1 treatments. As a matter of fact, if one treatment is doing
particularly badly, one may argue that it is unethical to add balls of that type as a
result of another treatment’s failure. Thus, it is reasonable and necessary to make
some modifications on the generating matrices.
In the 1990’s, discussions about adaptive design concentrated on the use of
different kinds of generating matrices and much progress was made. Anderson et
al (1994) discussed an urn scheme where a success on treatment i generated one
ball of type i, and a failure generated a proportional number of balls (to the urn
composition at the previous stage) for the other K− 1 types. Li (1995) proposed a
design that only generated balls of the same type with a success, but added nothing
when the response was a failure. This leads to a diagonal generating matrix. In
both of the models, the theoretical results might be expected to be difficult to
obtain because the generating matrix was random and dependent on all of the
previous splits and generations. Nevertheless, Bai et al (2002) proposed a new
adaptive design for multi-arm clinical trials, where the adding rule is proportionally
dependent on the success rate of each treatment. In this model, at the nth stage,
if a successful response on treatment k is obtained, additional one ball of type k is
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added; if it is a failure, proportional balls of the other K−1 types are added based







balls of type j is added, where Sn,j is the total number of successes of treatment
j in the n stages and Nn,j is the number of patients treated by treatment j. The
adding rule is quite reasonable. Although the design is no longer a GPU model,
the authors show that the design has some desirable asymptotic properties.
Durham and Yu (1990) proposed a type of modified play-the-winner rule. Ac-
cording to this rule, balls are added only if a success is obtained, but the urn
remains unchanged otherwise. Later in 1998, Durham et al (1998) showed that
this urn can be embedded into a continuous Markov process and the asymptotic
normality can be established accordingly. By assuming the probability of success
as p = (p1, p2, . . . , pK), and defining p





1 if pi= p
∗ ;
0 otherwise,
if the superior treatment is unique. Consequently, this rule will assign almost all
of the patients to the superior treatment.
Another characteristic of the previous models is that the number of balls added
at each stage is nonnegative. For the general case with homogeneous generating
matrices, Smythe (1996) studied the property of urn models with possible negative
entries in the adding rules. In such a model, there is possible removal of balls. In
his paper, the following assumptions are made: (1) the total expected number of
balls added at each stage is a constant; (2) E(d2i,j) < ∞, where di,j is the (i, j)th
element of the adding rules; and (3) the generating matrixH has a maximal positive
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eigenvalue of multiplicity 1 with strictly positive left eigenvector. In addition,
among the other eigenvalues, the largest real part is not greater than 1/2. Under
these assumptions, Yn andNn are both asymptotically normally distributed if they
are suitably normalized.
As for the nonhomogeneous case, Bai and Hu (1999) established asymptotic
theorems. By assuming that the row sums of the generating matrices are constant










where V = (v1, v2, . . . , vK) is the unit left eigenvector of H corresponding to the
maximal eigenvalue λ1.
In addition, if τ ≤ 1
2
, where τ = max{0, Re(λ2), . . . , Re(λs)} and λj is the
jth eigenvalues of H, j = 2, . . . , K, Yn is asymptotic normal and the form of the
variance-covariance matrix is given.
However, in the model, although the generating matrices seem to be non-
homogeneous, the second assumption makes them asymptotically homogeneous,
which limit the practicability of the model. To further relax the constraint on
the generating matrices, we suggest the use of nonconvergent generating matrices.
Establishing the asymptotic theorems for adaptive designs with nonconvergent gen-
erating matrices should be more useful as illustrated in the following examples:
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Example 1. Suppose that in a trial, the patients’ responses to the treatment
show a time trend, say a seasonal alternation, then the generating matrices may
diverge. Let pik = P (ηi = 1|T = k), for i = 1, 2, . . . , n and k = 1, 2, . . . , K, be the
probability of success for the ith patient if treatment k is employed. If the patients’
responses change over time, they are different as time elapses. Then, for fixed k,
pik are not identical for different i. Since Hi depends on (pi1, pi2, . . . , piK), in the
case that pik does not converge, the generating matrices diverge as i increases.
Example 2. Since, in a clinical trial, the objects are human beings, it is not
ethical to prolong a trial unnecessarily since it may assign more patients to the
inferior treatment. With the progress of the trial, once the accumulated outcomes
favor one treatment over the others, more patients ought to be assigned to the
better treatments gradually. Thus, the change of the urn composition is accelerated
simultaneously. Consequently, the trial is expedited. In this way, the adding rules
are skewed and the generating matrices may diverge.
Example 3. If the probability of success is affected by some observable covariates
at stage i, i.e. pik = pik(ϕi), where ϕi = (ϕi1, . . . , ϕil)
′, ϕi1, . . . , ϕil are independent
covariates and ϕ1, . . . , ϕi are independent, the corresponding generating matrices
may not converge in this case.
Example 4. To meet the ethical requirement, we need the adding rules to be
dependent on all or part of the previous results. Therefore, the conditional expec-
tation of the adding rule E(Dn|Fn−1) depends on the past outcomes. However, the
outcomes are random and they may not converge and the conditional generating
matrices may become divergent.
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The purpose of the third part of this thesis is to determine whether the urn
composition will stabilize and asymptotic properties hold when nonhomogeneous
generating matrices are adopted. In Chapter 4, we will propose a type of simplest
adaptive designs associated with nonconvergent generating matrices. In the pro-
posed model, two different generating matrices are used alternately. In this case,
the generating matrices do not converge and have two different limiting points
instead. Under some assumptions, we can show that as n increases, the urn com-
position will stabilize. Besides, we have shown that regardless of whether n is odd
or even, asymptotic normality holds. Moreover, Monte-Carlo simulation is carried
out and the results are consistent with the theoretical ones.
Based on the results in this chapter, adaptive designs associated with more
flexible generating matrices can be performed.
Some other researchers established central limit theorems for a linear combina-
tion of the urn composition. For example, using moment method, Freedman (1965)
showed the asymptotic theorem on the urn composition for Friedman’s urn. In his





For the GPU, Athreya and Karlin (1968) proved the limiting distribution of the
urn composition using the theory of branching process. Assume that E(d2ij) <∞,
when dij is the (i, j)th element of the unique adding rule D. Let λi be an eigenvalue
other than the maximal one, λ, with associated right eigenvector ξi. Then, for a
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linear combination of the elements in Yn, we have the following limiting results:
If λi < λ/2,
n−
1
2Ynξi ∼ N(0, c1);
if λi = λ/2,
(n log n)−
1
2Ynξi ∼ N(0, c2),
where c1 and c2 are some constants.
Although this paper shows the limiting distribution of linear combinations of
urn composition on the eigenvectors, the exact value of the variance term is not
given. In addition, the covariance terms between the eigenvectors belonging to
different eigenvalues are not studied. Moreover, there are many other linear combi-
nations of the urn composition are not considered, especially when some eigenvalues
of the generating matrix are not simple. On the other hand, in Bai and Hu (1999),
the general form of the variance is given, where K ≥ 2, which is a generalization
of the previous models. But in the case that τ , the second greatest real part of all
the eigenvalues, equals 1/2, the calculation of the variance-covariance matrix is too
rough and fails to show the minute differences between the entries.
A solution to this problem is provided in Chapter 5, where we studied the
asymptotic properties of a linear transformation of Yn on ξ, where ξ is a matrix
consisting of s blocks and the ith block of ξ is a matrix containing the vectors in the
basis of the cyclical space relative to H− λiI, i = 1, 2, . . . , s. Using the martingale
approach, we will establish the strong consistency and asymptotic normality of
Ynξ. Further, we provide an accurate expression of the variance-covariance matrix.
Especially, in the case that τ = 1/2, each element in the variance-covariance matrix
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has a different order, which corresponds to the different layer of the cyclic space
defined by H and some λi. From the results in Chapter 5, we can derive the
property of RPW rule and GPU rule easily.
1.3 Some Preliminary Results
In this section, we list some important preliminary results that will be used repeat-
edly throughout the next few chapters.
1.3.1 An Identity and a Limit




























1.3.2 Preliminary Results on Matrices
Definition In this thesis, for a random variable X or a random matrix X =<<





2 , where i = 1 . . .m, j = 1 . . . n.
In addition, the following lemmas will also be applied in this thesis.
Lemma 1.1 Suppose H is a K-dimensional non-negative matrix with the sum
of each row a constant c, there exists a maximal eigenvalue, which equals c, and
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a corresponding left eigenvector V = ( v1 v2 . . . vK ), with vi ≥ 0 for i =




Proof. This is a result about non-negative matrix in Minc H. (1988).
Lemma 1.2 Suppose that H is a K × K irreducible matrix with K eigenvalues,
1, λ2, . . . λK, then there exists a invertible matrix T, such that
T−1HT = J =

1 0 . . . 0
0 J2 . . . 0
. . . . . . . . . . . .




λt 1 0 . . . 0
0 λt 1 . . . 0
. . . . . . . . . . . . . . .
0 0 . . . λt 1
0 0 0 . . . λt

.
where it is possible that λi = λj for some i 6= j and 2 ≤ i, j ≤ K.
Define τ = max{0, Re(λ2), Re(λ3), . . . , Re(λK)} and the order of Jt as νt and

























1.3.3 Preliminary Theorems on RPW Rule
In an adaptive design using the RPW rule, if the generating matrix is homogeneous,




→ V a.s. as n→∞
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1.3.4 Preliminary Results on Martingales




Xi,Fn, n ≥ 1} be a zero-mean, square-integrable martingale. Then,




In the following chapters, the martingale central limit theorem will be used repeat-
edly. Here, we list it as a lemma. The proof of the lemma can be found in Hall
and Heyde (1980).
Lemma 1.5 Martingale Central Limit Theorem
Let {Si,Fi, 1 ≤ i ≤ n} be a zero-mean, square integrable martingale array with
differences Xi, and let η
2 be an a.s. finite random variable. Suppose that
max
i







X2i ) is bounded in i (1.8)









In lemma 1.5, the condition (1.7) is a Lindeberg type condition.
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1.4 Organization of the Thesis
In Chapter 2, we propose a new type of adaptive design which can be used when
responses are delayed and establish the asymptotic theory of it; the limiting distri-
bution of adaptive design with missing responses is studied in Chapter 3; Chapter
4 introduces a nonconvergent model and shows the asymptotic normality of it;
Chapter 5 focuses on the property of a linear combination of Yn and Nn; Chapter
6 presents some topics for future research and the programs for simulation are given
in the appendix.
Chapter 2
A Type of Adaptive Design with
Delayed Responses
2.1 Introduction
In most of the previous research, the patients’ responses are assumed to be in-
stantaneous, i.e. they are available before the entry of next patient. However, in
practice, the patients’ responses may be delayed for several stages or may not oc-
cur at all. Due to the scarcity of resources, it is impossible to trace each patient’s
response if it is delayed for too long. Thus, in the chapter, we employ a model,
which discards those responses that are delayed for more than M stages, where M
is some finite constant defined for each specific trial.
For the adaptive design using urn models when responses are delayed, the goal
of this chapter is to establish the asymptotic properties.
After thorough investigation of the design, we conclude that this design has the
26
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following advantages:
(1) the total number of patients assigned to the better treatment is greater than
that in the 50-50 randomization, which is ethical for the patients in the trial phase
by increasing the overall success rate;
(2) the asymptotic properties are retained, which are good properties for making
inference and the power is high;
(3) through an appropriate choice of M, we can reduce unnecessary waste of
resource on tracing the responses that are delayed for too long.
2.2 Formulation of the Model
In a clinical trial when responses are delayed, if a patient’s response is still not
available after M stages, we will stop tracking the response. Here we can choose
M as a finite constant according to the nature of each specific trial. Suppose
there are K treatments for comparison, where K ≥ 2. Yn = (Yn,1, Yn,2, . . . , Yn,K )
denotes the urn composition at the nth stage. The possible responses have L types,
i.e., ri = 1, 2, . . . , L and ϕi is the treatment indicator for the ith patient, i.e., ϕi = j
if patient i is assigned to treatment j, where j = 1, 2, . . . , K. In addition, another
indicator function M riϕi(i, j) given treatment ϕi and response ri, where
M riϕi(i, j) =

1 if the ith patient’s response occurs after exact j stages;
0 otherwise, where j ≤M.
M riϕi(i, j) is used to indicate after how many stages the response of the ith patient
occurs if treatment ϕi is adopted and the response is ri. For fixed i and corre-
CHAPTER 2. ADAPTIVE DESIGN WITH DELAYED RESPONSES 28
sponding ϕi and ri, if the response of the ith patient occurs within M stages, there
exists only one j that satisfies M riϕi(i, j) = 1; otherwise, if the response is delayed
for more than M stages, all M riϕi(i, j) = 0.
In this chapter, the following assumptions are made:
Assumption 2.1 Assume that the patients’ times to responses are independent of
the treatment allocation and the response generated. And they are independent of
each other and are identically distributed.
Explicitly, the time to response of the ith patient, ti, follows the same distrib-
ution regardless of the treatment employed and the response generated, for all
i = 1, 2, . . . , n. Therefore, M riϕi(i, j) = M(i, j). On the other hand, for simplicity,
we can assume that ti takes on M +1 forms, they are, ti = 1, 2, . . . ,M and ti > M
with probability p1, p2, . . ., pM and pt>M respectively. Also, if the time to response
ti is continuous, it can be discretized to follow the distribution described above.
When the response at the ith stage are observed, the urn composition is adjusted
by an adding rule Di,where
Di =

a11ηi + b11(1− ηi) a12ηi + b12(1− ηi) · · · a1Kηi + b1K(1− ηi)
a21ηi + b21(1− ηi) a22ηi + b22(1− ηi) · · · a2Kηi + b2K(1− ηi)
· · · · · · · · · · · ·
aK1ηi + bK1(1− ηi) aK2ηi + bK2(1− ηi) · · · aKKηi + bKK(1− ηi)

Here, Di is a K × K matrix with the kth row determining how to adjust the
urn composition based on the ith patient’s response if he is assigned to treatment
k. Without loss of generality, we may assume that the total number of balls






bkj = 1 for
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any k = 1, 2, . . . , K. Thus, the sum of the entries in each row of Di equals 1.
In addition, we assume that Di=D. Moreover, a row vector Xi represents the
selection state at the ith stage, i.e. only the kth element of Xi is 1 if treatment k
is selected, with all the other elements 0. {Fn} is defined as the σ field generated
by {Y0,Y1, . . . ,Yn}.
Assumption 2.2 Assume that Di and Xi are independent conditional on {Fi−1}.
In this model, the generating matrix H = E(Di|Fi−1) is homogeneous. Since
the sum of each row in H is also 1, from Lemma 1.1, there exists a maximal
eigenvalue 1 and a corresponding left eigenvector V, whose elements are all non-




1. Moreover, except 1, H has another K−1 eigenvalues, denoted by λ2, λ3, · · · , λK.
It is possible that λi = λj for some i and j and it is assumed that the total number
of different eigenvalues is s.
Under this circumstance, the following equality holds:




M(i, n+1− i)XiDi represents the number of balls added
at the nth stage based on the occurrences that occur at this stage, which result
from the allocation of the (n−M + 1)th ( or first ) to the nth patients.
The following recursive relationship exists:
Yn = Yn−1 +Wn
= Yn−1 + E(Wn|Fn−1) +Qn























Yi,j denotes the total number of balls in the urn at the ith stage.
2.3 Asymptotic Properties of Yn
2.3.1 Strong Consistency








pi is the probability that a patient’s time to response occurs within M
stages and is recorded and used to adjust the urn composition.
The lemma implies that as the number of patients recruited increases, the total
number of balls in the urn is proportional to n, where the ratio is p.
Proof. From the fact that the sum of each row of Di or Xi is 1, we can obtain






M(i, j + 1− i)XiDi1′
































It follows that the modulus of
1
n











































M(i, l)] = p and
M∑
l=1
M(i, l) − p is bounded, it follows that there exists






















M(i, j)− p]|| = O( 1√
n
).
On the other hand, in the second term of (2.2), since M is a finite constant, the






(|Yn| − np)|| = O( 1√
n
).
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By Chebychev inequality, it implies that
|Yn|
n
→ p in probability.
Using subsequence method, we can show that
|Yn|
n
→ p almost surely.
In the proof of Lemma 2.1, we also learn that |Yn| − np = Op(
√
n).
Assumption 2.3 Assume that the generating matrix H is non-negative and irre-
ducible.
From Lemma 1.2, we know that H can be transformed into a Jordan canonical
form J, the first column of T is (1, 1, . . . , 1)′ and the first row of T−1 is V.
Also, we assume Jk is νk-dimensional and define τ = max{0, Re(λ2), Re(λ3), . . . , Re(λK)}.




|Yn| → V = ( v1 v2 · · · vK ) a.s.,
where V is the left eigenvector of H corresponding to the maximal eigenvalue 1




Remark 2.1 Theorem 2.1 implies that although some of the responses are not
recorded, the limiting point of the urn composition is not affected and is the same
limit as in the case when responses are not delayed.
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Proof.























Now we need to determine the modulus of Rn.





















|Yn−1| || = ‖
(|Yn−1| − |Yk−1|)Yk−1




The equality follows from the fact that |Yn−1| − |Yk−1| is finite and Yk−1|Yk−1| is
bounded by 1.
On the other hand,











) +Yn−1Sn +Rn +Qn,
CHAPTER 2. ADAPTIVE DESIGN WITH DELAYED RESPONSES 34
where Sn =
(|Yn−1| − np)H
n|Yn−1| . From the proof of Lemma 2.1, ‖Yn−1−np‖ = O(
√
n),
it is obvious that ‖Sn‖ = O(n− 32 ) for n ≥M .
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n
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) · · · (I+ H
n
)
for i = 0, 1, . . . , n− 1 and Bn,n = I.
To show the strong consistency of Yn, it is more convenient to start with that of
YnT. From the fact that the elements in the first column of T are all 1 and the
result of Lemma 2.1, it is obvious that
1
n








Now, the first element in
1
n
YnT is determined. The next step concentrates on
the proof of the elements in YnT−, where T− denotes the matrix T with the first
column removed.
Therefore, in (2.4), we can do a transformation on Yn.





























) · · · (I+ J
n
).
and B˜n,i,j denotes the jth block of B˜n,i.




























The equalities follow from the preliminary results in chapter 1.













for any  > 0.
Similarly,
||Y0TB˜n,0,j|| = O(nRe(λj) logνj−1 n) = o(nRe(λj)+).
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Alternatively, if τ =
1
2





































































(log(n)− log(x− 1))ν−1d log(x− 1)








































< τ < 1, similarly, we can prove the modulus of all the three terms in (2.3)
are of o(n).
Therefore, all the elements in
1
n
YnT− tend to 0 almost surely, which implies
1
n
YnT→ ( p 0 0 · · · 0 ) almost surely.




Yn → pV = p ( v1 v2 · · · vK ) a.s.
Coupled with Lemma 2.1, it is obvious that
Yn
|Yn| → V = ( v1 v2 · · · vK ) a.s.
The proof of Theorem 2.1 is complete.
2.3.2 Asymptotic Normality
Assumption 2.4 Assume that τ , the largest real part of all the eigenvalues of H
except 1, is not greater than
1
2
and ν = max
i
{νi : Re(λi) = τ}.
Assumption 2.5 Assume that E(Q∗nQn|Fn−1)→ A and ||E(Q∗nQn|Fn−1)−E(Q∗nQn)|| →
0.










Σ) if τ <
1
2










Σ) if τ =
1
2
, where the form of Σ is to be defined later.





, we first investigate the asymptotic normality of n−1/2(Yn − EYn)T.
To find ΣY =
1
n
var(YnT), we divide it into four components and calculate each




(I) Since the first element of (Yn − EYn)T is |Yn| − E|Yn|, from the proof of
Lemma 2.1, we know that
















According to the definition of M(i, j), we know that M(i, j) ∼ Bernoulli(1, pj),
where t ≤M .
It follows that










var(|Yn| − E|Yn|)→ p(1− p).






In the proof of Theorem 2.1, we know that
YnT
|Yn| → (1 0 · · · 0) almost surely,
which implies YnT− = op(|Yn|). In addition, in a block B˜n,i,j, where j ≥ 2, the
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) 0 · · · 0
· · · · · · · · · · · ·































)λg logh(n/j)→ ( 1
1− λg )
h+1,
where k = 2, 3, . . . , νg and h = 0, 1, . . . , νg − k and the other elements in the block
are all 0.
(III) Obviously, Σ21 is the complex conjugate transpose of Σ12.










































































where g, h ∈ [2, s] are integers.
It follows that







































E(M(i, n + 1− i)D∗iX∗iXiDi|Fn−1)

















































s′t′(1− λ¯g − λh)s′+t′+1 [T
∗
gATh](s−s′,t−t′)
where [T∗gATh](m,n) is the (m,n)th element of the matrix T
∗
gATh and λ¯h represents
the complex conjugate of λh.
Hence, the form of ΣY is determined.
Since we have assumed that the total number of balls added upon the occurrence
of each response is 1 and M is a finite constant, it follows that condition (1.6)-(1.8)
are satisfied. Next, we will show the Lindeberg-type condition. Since we know










We have shown that the third term is the leading term.
n∑
i=1
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Therefore, if τ <
1
2





















































for any  > 0 arbitrarily small.










} → 0 for any fixed i.
From the martingale central limit theorem,
n−1/2(Yn − EYn)T ∼ N(0,ΣY ).














where Σ = (T∗)−1ΣYT−1.
On the other hand, if τ =
1
2
, the asymptotic normality still holds. However,





−ν n rather than n
1
2 . In this
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For each block in the matrix Σ22, if Re(λg) =
1
2
, λg = λh for some g, h =
2, 3, . . . s and νg = νh = ν, the (ν, ν)th element of the block is approximated by
1
(ν − 1)!(ν − 1)!(2ν − 1)[T
∗
gATh](1,1).
And all the other elements in the matrix tend to 0.


















The proof of Theorem 2.2 is now complete.
Example 2.1 Adaptive Design Based on RPW Rules
In a clinical trial, there are two treatments, 1 and 2, available with probability
of success p1 and p2 respectively. Correspondingly, there are two types of balls,
type 1 and type 2, in the urn. Suppose that the adjustment made upon the ith
patient’s response depends on the observed responses, where
Di =
αηi + (1− α)(1− ηi) (1− α)ηi + α(1− ηi)
(1− α)ηi + α(1− ηi) αηi + (1− α)(1− ηi)
 ,




1 if the ith patient’s response is a success.
0 otherwise.
That means, if the patient is assigned to treatment 1, α type 1 balls and 1−α type
2 balls are added into the urn if the response is a success, 1 − α type 1 balls and
α type 2 balls are added otherwise; on the other hand, if treatment 2 is adopted,
the urn is adjusted by adding 1− α type 1 balls and α type 2 balls upon a success
and α type 1 balls and 1− α type 2 balls, otherwise.
Thus, the generating matrix is
H =
αp1 + (1− α)q1 (1− α)p1 + αq1
(1− α)p2 + αq2 αp2 + (1− α)q2
 .
Hence, H has two eigenvalues, 1 and (2α−1)(p1−q2). The unit left eigenvector
associated with eigenvalue 1 is
V = (
(1− α)p2 + αq2
(1− α)(p1 + p2) + α(q1 + q2)
(1− α)p1 + αq1
(1− α)(p1 + p2) + α(q1 + q2) ) ,
where pj = E(ηi|treatment j).
Suppose, for each patient, the time to response, ti, follows a discrete uniform
distribution on [1, 2, 3, 4, 5] no matter which treatment is used and what the re-
sponse is. Take M to be 4, so that the responses that occur after 4 stages are
ignored. Hence, p = 0.8.
From Theorem 2.1, we know that as n→∞,
Yn
|Yn| → V a.s.
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where ΣY is given in the steps (I) to (IV).






2 + (1− 2α)(q1v1 + p2v2) α(1− α)
α(1− α) α2 + (1− 2α)(p1v1 + q2v2

We can find the expression of ΣY :
ΣY =
 p(1− p) p
(d˜11 + d˜12)v2 − (d˜12 + d˜22)v1
1− λ2
p


























where Σ˜ = Σ22
 1 −1
−1 1
 and Σ22 = d˜11v22 + d˜22v21 − 2d˜12v1v2.
2.4 Asymptotic Properties of Nn
In fact, in a clinical trial, a more interesting and useful topic is the proportion
of patients assigned to each treatment. From an ethical point of view, we would
like to allocate more patients to the better treatment. However, to make reliable
inference, we hope that there are enough patients in each treatment.
In this section, on the basis of the asymptotic properties of Yn, we investigate
the strong consistency and asymptotic normality ofNn, whereNn = (Nn,1, · · · , Nn,K)
is a vector denoting the number of patients assigned to each treatment in the n
trials.
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2.4.1 Strong Consistency
Theorem 2.3 Under the assumptions of Theorem 2.1,
Nn
n
→ V almost surely,
where V is defined in the last section.
Remark 2.2. Theorem 2.3 implies that although some of the patients’ responses
are ignored, asymptotically, the proportion of patients assigned to each treatment
is stable and is the same as in the no-delay case.











































E[(Xi − E(Xi|Fi−1))(Xi − E(Xi|Fi−1))′].
Since ||Xi|| = 1 and ||Xi − E(Xi|Fi−1)|| is bounded, it follows that for all n ≥ 1,





























(Xi − E(Xi|Fi−1))→ 0 a.s.
CHAPTER 2. ADAPTIVE DESIGN WITH DELAYED RESPONSES 47






|Yi−1| → V a.s.




The proof of the Theorem 2.3 is complete.
2.4.2 Asymptotic Normality













(Nn − ENn) L→ N(0, Σ˜),
where the form of Σ˜ is to be defined later.
Proof. To show the asymptotic normality of Nn, it is convenient to study that
of NnT first.




var(NnT) are both 0, i.e., Σ˜N =
 0 0
0 Σ˜22
. Thus, it is suffice to show





















































































In addition, in (2.9), the third term is fixed. Thus, to show the asymptotic






















var(U) consists of four terms, denoting by













The last equation follows from the fact that VT− → 0.
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· · · · · · · · · · · ·



































(j/i)−λg logl(i/j)(1 + o(1))→ ( 1
1− λg )
l+1,
where h = 1, 2, . . . , νg and l = 0, 1, . . . , νg − h.
(III) Obviously, the third term is the complex conjugate transpose of the second
term.
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where g, h are integers with g, h ∈ [2, . . . , s].





















Since both s and t are fixed and finite, if τ <
1
2













































































































































































































(1− λ¯g)−(t′−l+1)(1− λ¯g − λh)−(s′+l+1).
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Hence, if τ <
1
2



















(1− λ¯g)−(t′−l+1)(1− λ¯g − λh)−(s′+l+1)][T∗gATh](s−s′),(t−t′).





On the other hand, if τ =
1
2




ENn). In this case, although there are still four terms in the asymptotic vari-
ance, the first three terms all tend to 0. Thus, there is only one term left in
1
n log2ν−1 n




, λg = λh and νg = νh = ν, the (ν, ν)th element in the block has
a limit
1
|λg|2[(ν − 1)!]2(2ν − 1), with all the other elements tending to 0. All the
other elements in the block tend to 0.
Now the asymptotic variance is determined. Since, we have made the assump-
tion that the total number of balls added upon the occurrence of each response is
1, the elements in the adding rule Di is bounded by 1. It follows that conditions
(1.6)-(1.8) are satisfied. In order to show the asymptotic normality, the next step















B˜i,j,− ) . (2.11)








B˜j,i,g in (2.11), the hth element
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approximately equals

















Since in (2.12), the first term is controlled by some constant, we only need to













































Therefore, it is also bounded. It follows that the Lindeberg-type condition holds.
On the other hand, if τ =
1
2

























The proof of Theorem 2.4 is complete.
Example 2.1 (continued)




where V is defined in the first part of the example.
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(Nn − ENn) is asymptotically




Σ˜22 = Σ˜1 + Σ˜2 + Σ˜3 + Σ˜4,
Σ˜1 = v1v2,





























In this section, with S-plus program, we simulate the process of the adaptive design
we have just discussed.
n1: the number of repetition of the trial;
n2: the total number of stages in each trial;
Di: adding rule at the ith stage, where
Di =
αηi + (1− α)(1− ηi) (1− α)ηi + α(1− ηi)
βηi + (1− β)(1− ηi) (1− β)ηi + β(1− ηi)
 ;
y1: matrix denoting the number of type 1 balls at each stage;
y2: matrix denoting the number of type 2 balls at each stage;
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N1: matrix denoting the number of patients assigned to treatment 1 in the n
stages;
N2: matrix denoting the number of patients assigned to treatment 2 in the n
stages;
M : the maximum number of stages observing the response;
For figure 2.1-2.14, the parameter used are listed as follows:
n1 = 5000, n2 = 1000, p1 = 0.9, p2 = 0.6, α = 0.7, β = 0.3 and we assume ti is
i.i.d. and has a discrete uniform distribution on [1, 5], M = 4 and thus p = 0.8. In
this case, λ2 = 0.2 and V = (0.575, 0.425).
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Figure 2.1: tsplot of Yn,1/|Yn|
Figure 2.2: tsplot of Yn,1/n
CHAPTER 2. ADAPTIVE DESIGN WITH DELAYED RESPONSES 56
Figure 2.3: tsplot of Yn,2/|Yn|
Figure 2.4: tsplot of Yn,2/n
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Figure 2.5: tsplot of var(Yn,1)/n
Figure 2.6: histogram of (Yn,1 − E(Yn,1))/
√
n
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Figure 2.7: QQ-plot of (Yn,1 − E(Yn,1))/
√
n
Figure 2.8: tsplot of var(Yn,2)/n
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Figure 2.9: histogram of (Yn,2 − E(Yn,2))/
√
n
Figure 2.10: QQ-plot of (Yn,2 − E(Yn,2))/
√
n
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Figure 2.11: tsplot of Nn,1/n
Figure 2.12: tsplot of var(Nn,1)/n
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Figure 2.13: histogram of (Nn,1 − ENn,1)/
√
n
Figure 2.14: QQ-plot of (Nn,1 − ENn,1)/
√
n
In the graphs, the mean and variance converge to the theoretical value repre-
sented by the solid lines, which means the simulation results are consistent with
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the theoretical results. The histograms are symmetric and bell-shaped and the
qq-plots are straight lines, which all support the normality.
For figure 2.15-2.18, the parameter used are listed as follows:
n1 = 5000, n2 = 1000, p1 = 0.8, p2 = 0.4, α = 0.8, β = 0.2 and we assume ti is
i.i.d. and has a discrete uniform distribution on [1, 5], M = 4 and thus p = 0.8. In
this case, λ2 = 0.12 and V = (0.636, 0.364).
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Figure 2.15: tsplot of Yn,1/|Yn|
Figure 2.16: tsplot of Yn,1/n
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Figure 2.17: tsplot of Yn,2/|Yn|
Figure 2.18: tsplot of Yn,2/n
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Figure 2.19: tsplot of var(Yn,1)/n
Figure 2.20: histogram of (Yn,1 − E(Yn,1))/
√
n
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Figure 2.21: QQ-plot of (Yn,1 − E(Yn,1))/
√
n
Figure 2.22: tsplot of var(Yn,2)/n
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Figure 2.23: histogram of (Yn,2 − E(Yn,2))/
√
n
Figure 2.24: QQ-plot of (Yn,2 − E(Yn,2))/
√
n
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Figure 2.25: tsplot of Nn,1/n
Figure 2.26: tsplot of var(Nn,1)/n
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Figure 2.27: histogram of (Nn,1 − ENn,1)/
√
n
Figure 2.28: QQ-plot of (Nn,1 − ENn,1)/
√
n
From these graphs, it is clear that the simulation results support the theoretical
results.
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2.6 Estimation Efficiency
Some may argue that since we have dropped some information, the efficiency of the
estimation may be compromised. On the other hand, they suspect the adaptive
nature of the trial may also affect the efficiency when it comes to estimation.
To examine the performance of the proposed design, we conducted simulation
studies and compare the result with that of 50-50 randomization and the design
that all delayed responses are collected.
Similar to the Example 2.1, we assume the patients’ times to response follow a
discrete uniform distribution on [1,2,3,4,5], the generating matrix is
H =
 0.8p1 + 0.2q1 0.2p1 + 0.8q1
0.2p2 + 0.8q2 0.8p2 + 0.2q2

In the following tables, we use Design I to denoted the proposed design, Design
II is the 50-50 randomization when responses are only tracked for 4 stages, as in
the Example 2.1, Design III is the adaptive design when we track and record all
the responses until they occur.
We will introduce some notations. N1, N2 are the number of patients assigned
to treatment 1 and treatment 2 in n trials; NR1 and NR2 are the number of
responses that are generated within the phase of trial; NS1 and NS2 are number
of success responses that are collected in the trial in each treatment.
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Table 2.1: Comparison of the Performance of Three Models
(p1, p2) = (0.8, 0.4), sample size=100
Design I Design II Design III
(N1, N2) (62, 38) (50,50) (62,38)
(NR1, NR2) (49,29) (39,39) (61,36)
(NS1, NS2) (39,12) (31,16) (49,15)
overall success rate 0.65 0.60 0.66
power 0.962 0.956 0.986
Table 2.2: Comparison of the Performance of Three Models
(p1, p2) = (0.7, 0.5), sample size=250
Design I Design II Design III
(N1, N2) (141, 109) (124,126) (141,109)
(NR1, NR2) (112,86) (99,99) (140,107)
(NS1, NS2) (79,43) (69,50) (98,54)
overall success rate 0.62 0.60 0.62
power 0.86 0.878 0.906
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Table 2.3: Comparison of the Performance of Three Models
(p1, p2) = (0.8, 0.2), sample size=100
Design I Design II Design III
(N1, N2) (66, 34) (49,51) (66,34)
(NR1, NR2) (52,26) (39,39) (64,33)
(NS1, NS2) (41,5) (31,8) (51,7)
overall success rate 0.59 0.50 0.60
power 0.998 1 1
From the tables, we conclude that, compared with 50-50 randomization, the
proposed design does not lose much power for making inference, especially when the
difference of treatment effects is large. However, the number of patients assigned
to the better treatment group is higher, thus, the overall success rate is higher.
On the other hand, compared with the model in which all the data are collected,
the overall success rate is comparable and the power is just a little lower. The
advantage of the proposed model is the saving of time and resources. In addition,
some may worry about that the imbalance sample size may affect power. From
the figures in Table 2.3, when the difference between treatment effects is great, the
power is not heavily affected.
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2.7 Conclusions
In this chapter, we developed a model which is applicable when responses are
delayed. After detailed investigation of the asymptotic properties of both Yn and
Nn, we can draw the following conclusions about the model:
(1) Both the urn composition and patients’ allocation converge almost surely to
the same limit as in the case when responses are not delayed. That means, the
limits are not affected by the delay mechanism and only depends on the generating
matrix employed. Moreover, the asymptotic normality holds in both cases, which
are good properties for making inferences. In addition, the order of the variance is
not affected;
(2) Since we only track each patient’s response for M stage, the duration of the
trial is reduced, which is practically useful. For each specific trial, we can choose
an appropriate M, such that if a response does not occur within M stages, it is
quite possible that the response will not occur at all. We will stop tracking such
patients, otherwise, we will waste a lot of resources on them. On the other hand,
it is for the benefit of the general population to finish the trial as soon as possible,
since they will depend on the result of the trial to choose the treatment they will
receive.
(3) In the phase of the trial, the number of patients in the better treatment group
and the total number of successes are higher than in the 50-50 randomization.
Moreover, the power is comparable. That means, the delay mechanism does not
destroy the efficiency of the test.
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(4) From each specific trial, we first choose an appropriate value of M based on
the nature of the trial. And α, β are determined such that we can achieve the
desired efficiency, such as the variance and the power. With all these preparation,
the clinical trial can be carried out accordingly.
However, there are still some limitations in the proposed model.
In the model, we assume that the time to response is independent of the treat-
ment assignment or the response. However, in practice, it is possible that this
assumption is violated. That is, the patients’ times to response show different
patterns depending on the treatment assignment or the responses generated.
In fact, we can relax the requirement. If we assume that the time to response
depends on both the treatment assignment and the response, but the probability
that a response occurs within M stages is fixed for any treatment assignment or
any response, the asymptotic expectation does not change and the variance is
only slightly affected. On the other hand, if this more relaxed condition fails, in
the model, the row sum of the generating matrix is not constant. Therefore, the
unique maximal eigenvalue does not exist and the following results fail. This topic
is of interest in the future research.
Chapter 3
Adaptive Design with Missing
Responses
3.1 Formulation of the Model
In Chapter 2, we assume that all the responses are collectible as long as they occur
within in the phase of the trial. However, in a clinical trial, it is possible that
some responses are missing from the experiment before they occur and are, thus,
unreachable. In this chapter, a new model is proposed, where it is assumed that
the responses may be delayed or be missed from the experiment.
Assumption 3.1 Assume that the processes of delay and missing are independent
of each other. In addition, for each patient, the time to response or the time to be
missed from the trial are independent of the treatment allocation and the response
generated.
75
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In addition, we assume that the response occurs within M stages with certain
probability function.
What’s more, in the sequel, {ti1} and {ti2} are defined as the number of stages
it takes the ith patient’s response to occur or be missed from the experiment. In
fact, in the experiment, only one of ti1 and ti2 can be observed.







, . . . ,
1
K
) and at the nth stage, it is Yn = (Yn,1,Yn,2, . . . ,Yn,K). At the nth
stage, the urn is adjusted by an adding rule Di if the response of the ith patient
occurs at this stage, where i = n−M + 1, n−M + 2, . . . , n; on the other hand, if
the ith patient’s response misses at the nth stage before it occurs, the urn remains
unchanged. For simplicity, we assume the row sum of Di is 1, i.e., the total number
of balls added into the urn is 1 upon the occurrence of one response.
The urn composition is determined by the following recursive relationship,














where {ωn,i} = {n + 1− i < ti1 < ti2}. Simply put, the urn composition depends
on the status of the first n−M patients’ responses and the responses of the (n−
M + 1)th to the nth patients that either occur or miss before the nth stage.
Define pii = P (ti1 < ti2). Since we have assumed that the patients’ times to
responses are independent and identically distributed and do not depend on the
treatment allocation or the response, it follows that pii = pi is constant. In addition,
we denote the generating matrix H = E(Di|Fi−1) for i = 1, 2, . . . , n.
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Assumption 3.2 Assume that the unique generating matrix H is irreducible and
has s different eigenvalues.
From this assumption, we know that H can be transformed into the Jordan canon-
ical form as defined in Lemma 1.2. In addition, we know H has a unique maximal




Then, the following lemma reveals the rule regarding the total number of balls





and |Yn| − npi = O(
√
n), where |Yn| is the total number of balls in the urn at the
nth stage.















where 1 = (1, 1, . . . , 1) is a K-dimensional row vector with all the elements 1 and
Xi is a row vector denoting the selection state, i.e., only the kth entry is 1 if
treatment k is selected with all the other elements 0.
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It further implies that
|Yn|
n
→ pi in probability.
On the other hand,
|Yn| − E|Yn| =
n∑
i=1








Using subsequence method, we learn that
|Yn|
n
→ pi almost surely.
The proof of the lemma is complete.
3.2 Asymptotic Properties of Yn
3.2.1 Strong Consistency
Assumption 3.3 Assume that Di and Xi are independent conditional on Fi−1.
With Lemma 3.1, we can move on to one of the main results in this chapter.
Theorem 3.1
Yn
|Yn| → V a.s.
Proof.
Based on the above discussion and the fact that P (n + 1 − i = ti1 < ti2) =
P (ti1 = n + 1 − i) · P (ti1 < ti2) = pipn+1−i for i = n −M + 1, . . . , n, we have the
following recursive relationship:
Yn = Yn−1 +
n∑
i=n−M+1
XiDi1{n+ 1− i = tn1 < tn2}

















|Yn−1|) +Rn +Qn, (3.2)
where, if n > M , Qn =
n∑
i=n−M+1
[1{n+ 1− i = tn1 < tn2}XiDi − pipn+1−i Yi−1|Yi−1|H]










||pn+1−i Yi−1|Yi−1| − pn+1−i
Yn−1
|Yn−1| ||
= pn+1−i|| Yi−1|Yi−1| −
Yn−1
|Yn−1| ||














It is easy to show that both terms are of O(
1
n










) +Yn−1Sn +Rn +Qn,
where Sn =
pin− |Yn−1|
n|Yn−1| H with ||Yn−1Sn|| = O(
1√
n
). It follows that

















) · · · (I+ H
n
).
CHAPTER 3. ADAPTIVE DESIGN WITH MISSING RESPONSES 80
For the simplicity of calculation, as in Chapter 2, we need to do a transformation
on Yn as follows:
















) · · · (I+ J
n
) and SiT =
pii− |Yi−1|
ipi|Yi−1| TJ.
































|Yn| → V almost surely.
The proof of the theorem is complete.
3.2.2 Asymptotic Normality
Assumption 3.4 Assume that τ , the second largest real part of all the eigenvalues




Assumption 3.5 Assume that E(Q∗nQn|Fn−1)→ A




(Yn − EYn) L→ N(0,Σ), if τ < 1
2
;
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1√
n log2ν−1 n
(Yn − EYn) L→ N(0,Σ), if τ = 1
2
,
where Σ is to be defined later.
Proof.
For the convenience of calculation, we calculate the variance ofYnT first, which











(1) The first element of YnT is
K∑
i=1










var(1{ti1 < ti2 ∩ ti1 ≤ n + 1− i})
→ pi(1− pi).
(2) To find the other elements in ΣY , we notice that














































(3) Obviously, Σ21 is the complex conjugate of Σ12.
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and T∗gATh = piT
∗
gD˜Th, for g, h = 2, 3, . . . , s.
Therefore, using similar techniques to those in Chapter 2, the form of Σ is




The variance of Yn can be obtained easily from Σ = T
∗−1ΣYT−1. Using the
techniques similar to that in section 2.2, Lindeberg condition is easily verified.
Therefore, martingale central limit theorem implies that the normality holds.
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On the other hand, when τ =
1
2
, the procedure to calculate the variance is










, where the form of Σ22 can be easily
obtained similarly to that in Chapter 2. From martingale central limit theorem,
the asymptotic normality holds.
The proof of the theorem is complete.
Example 3.1
Suppose in an adaptive design, a patient’s time to response follows a discrete
uniform distribution on [1, 2, 3, 4] and the time that the response is missing from




The generating matrix used is
H =
αp1 + (1− α)q1 (1− α)p1 + αq1
(1− α)p2 + αq2 αp2 + (1− α)q2
 .
Hence, H has two eigenvalues, 1 and λ2 = (2α − 1)(p1 − q2). The unit left
eigenvector associated with eigenvalue 1 is
V = (
(1− α)p2 + αq2
(1− α)(p1 + p2) + α(q1 + q2)
(1− α)p1 + αq1
(1− α)(p1 + p2) + α(q1 + q2) ) ,
where pj = E(ηi|treatment j).
From Theorem 3.1, we know that
Yn
|Yn| → V a.s.






(Yn − EYn) L→ N(0,Σ)
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where
Σ =
 pi(1− pi) pi
(d˜11 + d˜21)v2 − (d˜12 + d˜22)v1
1− λ2
pi
(d˜11 + d˜21)v2 − (d˜12 + d˜22)v1
1− λ2 pi









(Yn − EYn) L→ N(0,Σ1)
where Σ1 = Σ22
 1 −1
−1 1
 and Σ22 = d˜11v22 + d˜22v21 − 2d˜12v1v2. where
D˜→
α
2 + (1− 2α)(q1v1 + p2v2) α(1− α)





3.3 Asymptotic Properties of Nn
3.3.1 Strong Consistency




where V is defined in section 3.2.
Proof.
In this section, the asymptotic properties of Nn is studied in detail, where, as
in the last chapter, Nn is a vector denoting the number of patients assigned to each
treatment in the n stages.
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Obviously, the first term tends to 0 almost surely. From the martingale strong law,
the second term will tend to E(
Yi−1
|Yi−1|)→ V almost surely.
The theorem is proved.
3.3.2 Asymptotic Normality













(Nn − ENn) L→ N(0, Σ˜N ),
where the form of Σ˜N is to be defined later.
Proof.
Since the first element of (Nn − ENn)T is 0, both the first row or column of
the variance are 0.














B˜i,j,− + op(Un) (3.3)
















We can show that if τ < 1/2, in (3.3), the first two terms are always the leading
terms.
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0 0 · · · 0
M2 0 · · · 0
· · · · · · · · · · · ·
0 0 · · · Ms

.
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Using similar method as in Chapter 2, we can obtain the expression of the variance.
Since M is bounded and the sum of each row of Di is 1, it is easy to show the
Lindeberg type condition is satisfied. From the martingale central limit theorem,
1√
n
(Nn − ENn) is normally distributed.
Similarly, if τ =
1
2




(Nn − ENn) follows a normal distribution.
Example 3.1 (continued)




where the form of V is given in the first part of the example.






(Nn − ENn) L→ N(0, Σ˜N),
where Σ˜N = Σ˜22
 1 −1
−1 1
, Σ˜22 = Σ˜1 + Σ˜2 + Σ˜3 + Σ˜4,
Σ˜1 = v1v2,


















(Nn − ENn) L→ N(0, Σ˜N),





Adaptive Design with Two
Alternating Generating Matrices
In an adaptive design, it is ethical to adjust the urn composition according to the
available responses at that stage. Whereas the adding rule is denoted by Di, the
generating matrix, denoted by Hi, is essential to the limiting behavior of the urn
composition.
The use of appropriate generating matrix should increase the probability of
using a superior treatment dramatically and decrease the possibility of employing
the inferior one. Therefore, sometimes we need to use different generating matrices
at different stages. The use of non-homogeneous generating matrix is vital, such
as in the examples in Chapter 1.
However, in literature, the research concentrates on the using homogeneous gen-
erating matrix. Even in Bai and Hu (1999), although the generating matrix seems
to be non-homogeneous, some restriction is imposed, which makes it asymptotically
88
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homogeneous.
In this chapter, we propose a type of simple adaptive design associated with
non-convergent generating matrix and discuss the limiting distribution. We also
carry out simulation studies and find that the results coincide with the theoretical
ones. In addition, the theoretical value of the model is discussed in detail.
4.1 Adaptive Designs with Two Alternating Gen-
erating Matrices For Two Treatments
Suppose, in a clinical trial, we want to compare the effectiveness of two treatments.
Accordingly, there are two types of balls in the urn to represent the two treatments
respectively. Without loss of generality, we assume that there are y0 balls of either
type at the beginning, where y0 = 1/2. Thus, Y0 = (1/2, 1/2). Then a ball is
randomly drawn at a time. Suppose that at the ith stage, after the type of the ball
is observed, it is replaced and the patient is assigned to the treatment according




1 if the ith patient’s response is success ;
0 otherwise .
Based on the patient’s response, the urn is adjusted according to the adding rules
Di, where
Di =
 ηiα1 + (1− ηi)(1− α1) (1− ηi)α1 + ηi(1− α1)
ηiα2 + (1− ηi)(1− α2) (1− ηi)α2 + ηi(1− α2)
 if i is odd
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and
Di =
 ηiβ1 + (1− ηi)(1− β1) (1− ηi)β1 + ηi(1− β1)
ηiβ2 + (1− ηi)(1− β2) (1− ηi)β2 + ηi(1− β2)
 if i is even,
where i = 1, 2,. . . , n; 0 < αj, βj < 1, j = 1, 2.
Here, without loss of generality, we assume the total number of balls added is
1.
The background corresponding to the scenario is that at the ith stage of the
trial, when a patient comes in, a ball is randomly drawn from the urn with replace-
ment. If the ball is of type j, where j = 1, 2, the patient is assigned to treatment
j accordingly. When the response is available, the urn is adjusted based on the
following rule: at odd ( even ) stages, if the outcome is a success, αj ( βj ) of the
jth type balls and 1 − αj (1 − βj) of kth type balls are added to the urn, where
k 6= j; otherwise, 1 − αj(1 − βj) of type 1 balls and αj (βj) of type 2 balls are
added. And the trial continues.
For simplicity of calculation, we define a1 = α1p1+(1−α1)q1, a2 = α2p2+(1−
α2)q2, b1 = β1p1+(1−β1)q1 and b2 = β2p2+(1−β2)q2; where pj = E(ηi| treatment j)
is the success probability of treatment j, and qj = 1 − pj, j = 1, 2. Then the
generating matrices are Hi = E(Di), where the generating matrix takes on two
forms, H1 and H2.
H1 = E(D2i−1) =




H2 = E(D2i) =
 b1 1− b1
b2 1− b2
 .
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Denote the urn composition at the ith split as Yi = (Yi,1, Yi,2), i = 1, 2, 3 . . . , n.
It follows that Yi,1 + Yi,2 = i+ 1, which is fixed for each i.
Moreover, the selection state Xi, i = 1, 2, 3, . . . , n, is denoted by
Xi = (Xi,1, Xi,2) =

(1, 0) if a type 1 ball is drawn at stage i;
(0, 1) otherwise.
4.1.1 Strong Consistency
Under the rules described above, we have the following relationship,
Yn = Yn−1 +XnDn.





where {Fi} = {σ(Y1,Y2, . . . ,Yi)}, i = 1, 2, 3, . . . , n, is a sequence of increasing
σ-fields generated by Y1,Y2, . . . ,Yi.
Assumption 4.1.1 Assume that the Di and Xi are independent conditional on
Fi−1.
Under Assumption 4.1.1, Y2n can be represented recursively as
Y2n = Y2n−1 +X2nD2n
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(4.1.1)






) · · · · · · (I + Hn
n
) with Bn,n = I and Qn =
XnDn − E(XnDn|Fn−1) is a sequence of bounded martingale difference.















The properties of Yn can be obtained from these two equalities. In addition,
we know that the generating matrices H1 and H2 are important in determining the
limiting distribution of Yn. Thus, we should spend some time investigating their
properties first.













1− a2 + b2
2
 .
Assumption 4.1.2 Assume thatH is irreducible with all the elements non-negative.
From the lemmas in Chapter 1, since the row sums of H are 1, there exists an
invertible matrix T, such that T−1HT has a Jordan canonical form,




where λ = 1 is the maximal eigenvalue of H and −1 < λ2 = a1 + b1
2
− a2 + b2
2
< 1
is the second largest eigenvalue of H.
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Denote V = (v1, v2) as the left eigenvector ofH with respect to λ. Let v1+v2 =











V = ( v1 v2 ) = (
a2 + b2
2 + a2 + b2 − a1 − b1
2− a1 − b1
2 + a2 + b2 − a1 − b1 ) .
Now, the convergence of EYn and Yn are given by the following theorem:
Theorem 4.1.1 Using the notation defined above, we have
1
n




→ V a.s. (4.1.5)
Remark 4.1 Here, we should note that the limit corresponds to the mean of the





E(Y2n)T and Z0 = Y0T.
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where S = T−1(H1H2 − H2)T =
 0 d1
0 d2
, where d1 and d2 are some finite






2n− 1) + Zn−1
S
2n(2n + 1)























) · · · (I+ 2J
2n− 1)
= (a) + (b).






































It follows that for all n ≥ 1, there exists a constant C1, such that


















































Therefore, |(b)| → 0 and, consequently, as n→∞,






































where e = (1, 0)′.
















= ( 1 0 ) .
From the fact that the first row of T−1 is V, it implies that
1
2n
E(Y2n)→ ( v1 v2 ) = V.
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In summary, we have shown that
E(Yn)
n
→ V as n→∞.
(4.1.4) is proved.
Proof of (4.1.5) To prove the almost sure convergence, first, we need to show
the variance converges to 0 at some rate. By employing the subsequence method,
almost sure convergence follows.
Now that
var(Y2nT)






















Then, We consider the two terms in (??) separately.
In fact, we can decompose T−1B2n,2iT into terms.
T−1B2n,2iT



































) · · · · · · (I+ 2J
2n− 1)






































= B˜2n−1,2i−1,1 + B˜2n−1,2i−1,2,







) · · · (I+ 2J
2n− 2)
and S˜ = T−1(H2H1 −H1)T, with the elements in the first column all 0 and those
in the second column bounded.
Then, from (4.1.7), we know
var(Y2nT)














where the covariance term is the sum of covariances between Qi and Qj (1 ≤
i 6= j ≤ 2n). It is easy to prove that since {Qi} is a sequence of bounded martin-
gale difference, each of the covariance terms equal 0, so does their sum, i.e. cov = 0.
To estimate the order of (4.1.8), we must study each element and filter out the
leading term. This is realized in the following steps.
First, notice that the first element of Y2nT is fixed, both the first row and
column of var(Y2nT) are 0.
Now,









) · · · S









) · · · S
(2j1 − 1)2j1 · · ·
S
(2j2 − 1)2j2 + · · · (I+
2J
2n− 1)







(2j2 − 1)2j2 · · ·
S
(2jl − 1)2jl .
The general term of B˜2n,2i,2 is the product of (I+
2J
2j − 1) and
S
2l(2l − 1), with the
restriction that there are at least one
S
2l(2l − 1) term.
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Since we know the first row and column of var(YnT) are both 0, while both
the first row and column of T′E(Q′2iQ2i)T are 0, S has the first column elements
all 0 and (I+
2J
2i+ 1
) has a diagonal form. Thus, we can rewrite the general term
of B˜2n,2i,2 as a matrix with the first column all 0.
Thus, in (4.1.7), only the (2, 2)th element of B˜2n,2i,2, denoted by bni will affect
the order of var(Yn), where bni is the product of 1 +
2λ2
2j − 1 and
d2
2l(2l − 1). Then
































≤ C3 · nλ2 1
iλ2+1
,
where C2, C3 are some constants.
Then, if M is a matrix with all the elements bounded and the first row and
column both 0, under the assumption that λ2 ≤ 1
2
, there exists some constant C4,










The further calculation is divided into three cases:
























































if 2 + 2λ2 > 1, i.e. − 1
2
































< λ2 ≤ 1. (4.1.9)



















O(1) if λ2 < 0;
O(logn) if λ2 = 0;
O(n2λ2) if 0 < λ2 ≤ 1. (4.1.10)
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Similarly, as for the odd terms in (4.1.8), the first row and column are both 0,




′E(Q′2i−1Q2i−1)TB2n−1,2i−1,1 has the same
order as defined by (4.1.10).
The last step is to determine the modulus of the remaining two terms in (4.1.8).
Since S2iS
′

































by Assumption 4.1.1, we have
(4.1.11) =

















′E(S′2i−1S2i−1)TB˜2n−1,2i−1,1| has the same order de-
fined by (4.1.11). Therefore, in (4.1.8), the modulus of var(Y2nT) is controlled by
(4.1.11), and so is var(Y2n).










































(T′)−1var(TYn)T−1, and all the elements inT and
T−1 are bounded by 1, thus, var[
1
n








E(Yn)→ V in probability.
Therefore, the almost sure convergence is obvious by employing subsequence
method.
The proof of the theorem is now complete.
4.1.2 The asymptotic variance
Before calculating the variance, we need some assumptions and preliminary results.
Assumption 4.1.3 Assume that λ2 ≤ 1
2
, i.e. a1 + b1 − a2 − b2 ≤ 1.
Assumption 4.1.4 Assume that E||E(Q′2nQ2n)−E{(Q′2nQ2n)|F2n−1}|| → 0 and




where Qˆ1 and Qˆ2 will be defined later.
Lemma 4.1.1 Under Assumption 4.1.4, E(Q′2nQ2n) → E{(Q′2nQ2n)|F2n−1} →
Qˆ2






where c2 = {β21p1 + (1− β1)2q1}v1 + {(1− β2)2q2 + β22p2}v2 − (b1v1 + b2v2)2.
Proof. From the results of Theorem 4.1.1, we know
E{(Q′2nQ2n)|F2n−1}















These equalities follows from the fact that X2n,1+X2n,2 = 1, X2n,1X2n,2 = 0 and
X22n,1 = X2n,1, X
2














E(Q′2nQ2n) = E{E(Q′2nQ2n)|F2n−1} → Qˆ2.
The lemma is proved.
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By symmetry, it is easy to show that






where c1 = {α21p1 + (1− α1)2q1}v1 + {(1− α2)2q2 + α22p2}v2 − (a1v1 + a2v2)2.
Theorem 4.1.2. The asymptotic variance of Yn is given by
U−2n var(Yn)→ Σ, as n→ ∞
where





















Proof. For the convenience of calculation, we start with var(Y2nT).
From (4.1.7), we only need to calculate the two leading terms. Thus, the vari-






Note that the first element of Q2iT is 0. We can denote T2 = (v2,−v1)′, i.e.












































































































where c = c1 + c2.
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Combining these two cases, we have
U−2n var(Yn)→ Σ,
The proof of Theorem 4.1.2 is complete.
4.1.3 Asymptotic normality
Theorem 4.1.3 Under the above assumptions, U−1n (Yn−EYn) is asymptotically
normal with mean 0 and variance-covariance matrix Σ, where Un and Σ are defined
in Section 4.1.2.
Proof. Firstly, from Section 4.1.2, we notice that U−2n T
′V ar(Yn)T tends to a
limit which implies U−2n var(Yn) tends to a limit Σ.
Now from (4.1.8) and the results in the last subsection,
{Y2n − E(Y2n)}T ∼
n∑
i=1











Since Qi is bounded, i = 1, 2, . . . , 2n, to prove the asymptotic normality, we
need only to check the Lindeberg condition.
Note that
Q2iTB˜2n,2i,1 ≤ ( 0 R1(n
i
)λ2 ) ,




where R2 is also a bounded random variable.
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)λ2 | > √nε}
= O(n2λ2−1)O(n1−2λ2)o(1)
= o(1)
→ 0 as n→∞.
This follows from the fact that P{|R2(n
i
)λ2 | > nε} → 0 for fixed i.











∣∣∣∣∣∣)→ 0 as n→∞.
Now, all the conditions are satisfied. By martingale central limit theorem, U−1n {Y2n−
E(Y2n)} is asymptotic normal with mean vector 0 and variance-covariance matrix
Σ.
By similar procedure, it is easy to check the Lindeberg condition also holds for
the case when n is odd.
Theorem 4.1.3 is proved.
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4.2 General Case
4.2.1 Formulation of the Model
Suppose, in a clinical trial, there are K treatments for comparison, where K ≥ 2
and, correspondingly, K different types of balls available in the urn. Assume,
initially, there is 1/K ball of each type. At a stage, when a patient comes into the
trial, a ball is drawn from the urn randomly with replacement and the patient is
assigned to treatment j according to the type j of the ball obtained. When the
patient’s response is observed, the urn is adjusted by the following rule: at stage
i, when i = 2m − 1 (i = 2m), m = 1, 2, . . ., if the response is a success, ajl(cjl)
balls of type l are added into the urn; otherwise, bjl (djl) balls of type l are added,













djl = 1. That is, the total number of
balls added each stage is 1. Hence, the adding matrix Di has the sum of each row
1 and is denoted by
Di =

a11ηi + b11(1− ηi) a12ηi + b12(1− ηi) · · · a1Kηi + b1K(1− ηi)
a21ηi + b21(1− ηi) a22ηi + b22(1− ηi) · · · a2Kηi + b2K(1− ηi)
· · · · · · · · · · · ·
aK1ηi + bK1(1− ηi) aK2ηi + bK2(1− ηi) · · · aKKηi + bKK(1− ηi)

if i = 2m− 1, and
Di =

c11ηi + d11(1− ηi) c12ηi + d12(1− ηi) · · · c1Kηi + d1K(1− ηi)
c21ηi + d21(1− ηi) c22ηi + d22(1− ηi) · · · c2Kηi + d2K(1− ηi)
· · · · · · · · · · · ·
cK1ηi + dK1(1− ηi) cK2ηi + dK2(1− ηi) · · · cKKηi + dKK(1− ηi)

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if i = 2m, m = 1, 2, . . ., where ηi = 1 or 0 according to whether the ith patient’s
response is a success or a failure.




H1 if i = 2m− 1;
H2 if i = 2m;
H1 =

a11p1 + b11q1 a12p1 + b12q1 · · · a1Kp1 + b1Kq1
a21p2 + b21q2 a22p2 + b22q2 · · · a2Kp2 + b2Kq2
· · · · · · · · · · · ·





c11p1 + d11q1 c12p1 + d12q1 · · · c1Kp1 + d1Kq1
c21p2 + d21q2 c22p2 + d22q2 · · · c2Kp2 + d2Kq2
· · · · · · · · · · · ·
cK1pK + dK1qK cK2pK + dK2qK · · · cKKpK + dKKqK

,
where pj=E(ηi|treatment j is employed).
Denote the urn composition at stage i as Yi = (Yi,1, Yi,2, . . . Yi,K), i = 1, 2 . . . , n






, . . .
1
K
), where Yi,j represents the number of jth type of balls in
the urn at the ith stage. Then it is straight-forward that
K∑
i=1
Yi,j = i+ 1.
The selection state at stage i is Xi = (0, 0, . . . 1, 0, . . . , 0), i = 1, 2, . . . , n, that
is, only the jth element of Xi is 1 if treatment j is used.
Assumption 4.2.1 Assume that Dn and Xn are independent conditional on Fn−1.
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From the previous assumptions and definitions, it is obvious that E(Xn|Fn−1) =
1
n
Yn−1. And we can define
Qn = XnDn − E(XnDn|Fn−1),
which is a sequence of bounded martingale difference adapted to {Fn−1}.
Now, Yn can be represented recursively as
Yn = Yn−1 +XnDn


















with I as an identity matrix and Bn,n = I.
It follows that
E(Yn) = Y0Bn,0 (4.2.2)
and




Define H to be the mean of the two different generating matrix. We need the
following assumption about H.
Assumption 4.2.2 Assume that H is irreducible with all the elements non-
negative.
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Since H is non-negative and the sum of each row is 1, there exists a maximal
eigenvalue 1, which is greater than the absolute value of the real part of any other
eigenvalue.
Assume that the left eigenvector of H associated with the eigenvalue 1 is V =




Therefore, there exists an invertible matrix T, such that
T−1HT = J =

1 0 . . . 0
0 J2 . . . 0
. . . . . . . . . . . .




λt 1 0 . . .
0 λt 1 . . .
. . . . . . . . . . . .
. . . . . . 0 λt

,
where λt is the eigenvalue of block Jt and the first column of T is (1, 1, . . . , 1)
′, the









Yn → V a.s. (4.2.5)




E(Yn)T and Z0 = Y0T.




























n− 1) + Zn−2
S
n(n+ 1)
















) · · · (I+ 2J
n− 1)
= (a) + (b),




















)S2 · · · 0
· · · · · · · · · · · ·
































































where C is some constant and δ > 0 is small enough, then (b)→ 0 and Zn ∼ (a).
























) · · · 0
· · · · · · · · · · · ·












1 0 . . . 0
0 0 . . . 0
. . . . . . . . . . . .



















nλt logl n(1 + o(1))→ 0
and e1 = (1, 0, . . . , 0), where t ∈ [2, 3, . . . , s] is an integer.
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Proof of (4.2.5) .
To prove the almost sure convergence, as in the 2-dimensional case, we need to
show that the variance will tend to 0 at some rate and the almost sure convergence
follows from subsequence method.




First, we note that {Yn−E(Yn)}(1, 1, . . . , 1)′ is 0, which means the first element
of {Yn − E(Yn)}T must be 0.

















∼ B˜2n−1,i,1 + B˜2n−1,i,2 if i is odd,
































To show the variance tends to 0, we much study each term in (4.2.6). From the









) · · · S
2j1(2j1 − 1) · · ·
S
2jl(2jl − 1) · · · I+
2J
2n− 1).



































































) if τ = −1
2
;
O(n2τ ) if −1
2
< τ ≤ 1;
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cause the first row and column of this matrix are both 0, the element in the first
row of B˜2n,2i,1 does not affect the order of their product. From the previous calcu-











































Using similar method, the calculation is easy and is divided into three cases:
(4.2.9) =

O(1) if τ < 0;
O(log2ν−1 n) if τ = 0;
O(n2τ ) if 0 < τ ≤ 1.
On the other hand, it is obvious that B∗2n−1,2i−1,1T
∗E(Q∗2i−1Q2i−1)TB2n−1,2i−1,2
has the same order as B∗2n,2i,1T
∗E(Q∗2iQ2i)TB2n,2i,2.
The last step is to examine the remaining two terms in (4.2.6). Using similar
techniques, we know
|B˜∗2n,2i,1T∗E(Q∗2iQ2i)TB˜2n,2i,1|






















< τ ≤ 1;








Y2n → V in probability.
Based on (4.2.1), the case for 2n+ 1 can be proven similarly.
The proof of the lemma is complete.
The almost sure convergence can be obtained by using subsequence method.
The proof of the theorem is now complete.
4.2.3 Asymptotic Normality
Assumption 4.2.3 Assume τ ≤ 1
2
, where τ is the greatest real part of all the
eigenvalues of H except 1.
Assumption 4.2.4 Assume ηi, the patients’ responses, are independent of each
other, where i = 1, 2, . . . , n .
This assumption requires that a patient’s response cannot affect the other’s.
Assumption 4.2.5 Assume E||E(Q∗iQi)− E(Q∗iQi|Fi−1)|| → 0 and
E(Q∗2iQ2i)→ Qˆ2
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and
E(Q∗2i−1Q2i−1)→ Qˆ1,
where Qˆ1 and Qˆ2 are to be defined later.
Now, we’ll give the explicit form of Qˆ1 and Qˆ2.




1, X22i,j = X2i,j and X2i,jX2i,l = 1 when j = l and 0, otherwise. In addition, from
Theorem 4.2.1, E(X2i,j|F2i−1) → vj as i → ∞, where j = 1, 2 . . . , K, then, the
(s, t)th element of Qˆ2 is given by
K∑
j=1
{(csjctjpj + dsjdtjqj)vj − (csjpj + dsjqj)(ctjpj +
dtjqj)v
2
j , where s, t ∈ [1, K] are integers.








where, by symmetry, the (s, t)th element of Qˆ1 is
K∑
j=1
{(asjatjpj + bsjbtjqj)vj −
(asjpj + bsjqj)(atjpj + btjqj)v
2
j , where s, t ∈ [1, K] are integers.
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Theorem 4.2.2 Under Assumptions 4.2.1-4.2.4, we have U−2n var(Yn) → Σ,


















where νi is the order of Ji and ν = max(νt : Re(λt) = τ)
Proof. In (4.2.7), since the first element of TE(Y2n−E(Y2n)) is 0, we conclude
that the first row and column of var(Yn) must be 0.











= (c) + (d).
Denote T = (1,T2, · · · ,Ts),
Using M− to denote the matrix M with the first column removed. The calcu-
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where g, h ∈ [2, s] are integers.















































s′t′(1− λ¯g − λh)s′+t′+1 [T
∗
gQˆ2Th](s−s′,t−t′),
where [M](m,n) is the (m,n)th element of the matrix M and λ¯h represents the
complex conjugate of λh.









s′t′(1− λ¯g − λh)s′+t′+1 [T
∗
gQˆ1Th](s−s′,t−t′).













































(s′ + t′ + 1)s′!t′!
[T∗gQˆ2Th](v−s′,v−t′)
∼ n
(v − 1)!(v − 1)!
log2v−1 n
(2v − 1) [T
∗
gQˆ2Th](1,1).





















[(v − 1)!]2(2v − 1) ,





















[(v − 1)!]2(2v − 1) .
In summary, if n is even, the form of U−2n var(YnT) is determined.
In addition, we can prove U−2n var(Yn+1)→ U−2n var(Yn), the limits also apply to
this case.
The proof of the theorem is complete.
Theorem 4.2.3 Under the assumptions of Theorem 4.2.2, we can show the as-
ymptotic normality, which is given by
U−1n {Yn − E(Yn)} L→ N(0,Σ),
where the variance-covariance matrix Σ is as specified in Section 4.2.2.
Proof.
From the previous exercise, we learn that







and note that U−2n T
∗var(Yn)T tends to a limit which implies U−2n var(Yn) tends
to a limit Σ.
CHAPTER 4. Adaptive Design With Two Alternating Gen Matrices 122
To prove the asymptotic normality, we need only to check the Lindeberg con-







Q2i (1 T2 · · · Ts )








) · · · 0
· · · · · · · · · · · ·

















































Now, since vg and h are both finite, for fixed j ∈ [0, h − 1] and any ε > 0, the



















































)→ 0 and P{Ani} →
0.
Now the Lindeberg condition is satisfied. Similarly, we can prove it also holds
for the second term in (4.2.11).
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Obviously, we can check the Lindeberg condition for Yn+1.




By martingale central limit theorem, U−1n (Yn − E(Yn)) is asymptotic normal
with mean 0 and variance-covariance matrix Σ.
The proof of the theorem is complete.
4.3 Monte Carlo Simulation and Results
In this section, Monte Carlo simulation is carried out to evaluate the results of the
theorems numerically, give a graphical view of the convergence of expectation and
variance, and further, to check the asymptotic normality.
Now, I will first introduce the procedure of the simulation.
Consider two treatments T1 and T2 with probability of success p1 and p2 re-
spectively, and, correspondingly, two types of balls in the urn,. In the process of
simulation, since the total number of balls in the urn at each stage is fixed, for sim-
plicity, we only investigate the number of type 1 balls, i.e. only Yi,1 is considered,
and that of the type 2 balls can be obtained easily.




At stage i, i = 1, 2, . . . , n2, if i is odd (even), a random number r1 which follows
Uniform(0, 1) distribution is generated. If r1 ≤ Yi−1,1
i
, which represents that a
type 1 ball is drawn, the patient is assigned to T1 and another random number
r2 ∼ U(0, 1) is generated. If r2 ≤ p1, it is regarded that the response to T1 is a
success, so additional α1 (β1) type 1 ball is added, in the simulation, it is realized
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by setting Yi,1 = Yi−1,1+α1 (Yi,1 = Yi−1,1+β1); if r2 > p1, we regard the response as
a failure, then add 1−α1 (1−β1) white ball into the urn, i.e. Yi,1 = Yi−1,1+1−α1
(Yi,1 = Yi−1,1 + 1− β1).
On the other hand, if r1 >
Yi−1,1
i
, which indicates a type 2 ball is obtained,
then the patient is assigned to T2. Then r2 is generated and the value is observed.
If r2 ≤ p2, which means a successful response and generates α2 (β2) type 1 ball
into the urn, then Yi,1 = Yi−1,1 + α2 (Yi,1 = Yi−1,1 + β2); if r2 > p2, we have
Yi,1 = Yi−1,1 + 1− α2 (Yi,1 = Yi−1,1 + 1− β2). The procedure is repeated until the
n2th stage.
In the simulation, the above program is run n1 times iteratively. To estimate
the expectation of Yn,1, we calculate the sample mean of the n1 observations of
Yn,1 for each n, where n = 1, 2, . . . n2; and we use the sample variance as the
estimation of the population variance. To check the normality, we use the n1
values of U−1n {Yn2,1 − E(Yn2,1)} to draw QQ plot and histogram, where the value
of E(Yn2,1) is obtained from Theorem 4.1.1.
For each set of parameters shown in Table 4.1, we have four graphs of S-plus
output.
The first one is the simulation result of
1
n
E(Yn,1) with the value of n on the
x-axis. In each figure, the theoretical result value is plotted as a solid straight line
as well as shown in Table 4.1.
The second figure is the simulation result of U−2n var(Yn,1) for different values of
λ2. Similarly, we have the theoretical vales both on the figure and in the table.
The third figure is the QQ plot for
1
Un
(Yn2,1 − EYn2,1). Here, we use the value
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of Yn2,1, the number of balls at the n2th stage. As we have known that if the dots
in the QQ plot lie on the straight line, it shows strong normality.
The last figure is the histogram used to check the normality. If the histogram
is symmetric and bell-shaped, the normality is concluded.
With S-plus, we have run the simulation for different parameters. The para-
meters used for each figure are shown in the table and the values of n1 and n2 are
shown in the caption of each figure.
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Table 4.1: Adaptive Design with Two Different Gen-matrices
p1, p2 α1 α2 β1 β2 λ2 v1 c1 + c2 Figure
0.9, 0.1 0.6 0.2 0.7 0.3 -0.08 0.648 0.034 4.1-4.4
0.9, 0.1 0.8 0.4 0.7 0.3 0.08 0.674 0.042 4.5-4.8
0.8, 1/15 0.95 0.9 0.85 0.7 0.5 0.48 0.257 4.9-4.12
0.9, 0.8 0.85 0.1 0.95 0.3 0.5 0.64 0.236 4.13-4.16
The graphs for the simulation results are shown below.
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Figure 4.1: n1=2000, n2=1000
Figure 4.2: n1=2000, n2=1000
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Figure 4.3: n1=2000, n2=1000
Figure 4.4: n1=2000, n2=1000
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Figure 4.5: n1=5000, n2=1000
Figure 4.6: n1=5000, n2=1000
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Figure 4.7: n1=5000, n2=1000
Figure 4.8: n1=5000, n2=1000
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Figure 4.9: n1=1000, n2=5000
Figure 4.10: n1=1000, n2=5000
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Figure 4.11: n1=1000, n2=5000
Figure 4.12: n1=1000, n2=5000
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Figure 4.13: n1=1000, n2=5000
Figure 4.14: n1=1000, n2=5000
CHAPTER 4. Adaptive Design With Two Alternating Gen Matrices 134
Figure 4.15: n1=1000, n2=5000
Figure 4.16: n1=1000, n2=5000
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From the graphs, the mean and the variance will converge to the theoretical
value as represented by the solid line in the graphs. The histogram is symmetric and
bell-shaped, which can support the normality. In addition, the qq-plot are straight
lines. Therefore, we can conclude that the theoretical results are supported by the
simulation results.
4.4 Conclusions
In this chapter, we proposed a simple adaptive design with nonconvergent generat-
ing matrices, which is in contrast to the adaptive designs associated with homoge-
neous generating matrices. In addition, we have obtained the asymptotic properties
of this new design.
From the results in the chapter, we conclude that although the generating
matrices do not converge in the proposed model, under some assumptions, the
urn composition will stabilize as the number of patients increases. Moreover, the
asymptotic normality still holds. Besides, the Monte-Carlo simulation is carried
out and the simulation results also support the theoretical ones.
However, in the model, although the generating matrices do not converge, the
mean of them is constant. In the model, the strong consistency corresponds to the
constant mean of the generating matrices. The limit is the left eigenvector of H.
Therefore, the convergence of the mean of the generating matrices may provide
a possible explanation of that of the expectations. As for the variance, firstly,
since the mean of finite number of the generating matrices is constant, the order
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of the variance should be the same as in the homogeneous case. This may explain
why the rates of convergence in the model is the same as that in the homogeneous
model. But the elements in the variance-covariance matrices are different. From the
formula of c, it is obvious that it is determined equally by the elements in both of
the two generating matrices no matter n is odd or even. Moreover, The asymptotic
normality is a common distribution for any large number of observations. In the
model, since both the expectation and variance converge at certain rates, as the
number of patients recruited tends to infinity, the asymptotic normality can be
shown easily using martingale central limit theorem.
From the results in the chapter, we further conclude that when the asymptotic
theories of adaptive designs based on GPU are investigated, the requirement of
homogeneous or asymptotic homogeneous generating matrices may not be essential
and can be relaxed to some extent. Urn models associated with nonconvergent
generating matrices may converge as well. In these nonconvergent models, the
limiting point of the urn composition and the rate of convergence are comparable
to those of the homogeneous models. Moreover, the asymptotic expectation and
the variance will stabilize to the limits that correspond to the mean of some of the
different generating matrices.
The proposed model has a practical importance. For example, in a trial, if we
want to treat male and female patients alternately and use different generating
matrices for them, we can used the proposed model. The asymptotic properties of
the model can provide a basis for making the inference.
However, there are still some aspects for improvement in the model. A problem
CHAPTER 4. Adaptive Design With Two Alternating Gen Matrices 137
is although the results in the thesis are helpful in clinical trials because it allows
flexibility of the generating matrices while does not affect the efficiency for making
inference, there are still some limitations in the model. For example, when we make
the assumptions, some restrictions are imposed on the generating matrices to make
them converge under some arithmetic operations, which limits the usefulness of our
models. Since in practice, if the generating matrices have a time trend or depend
on some covariates that may diverge, they will not converge in any format. In this
sense, the usefulness of the model is limited. But, due to the practical importance
of nonconvergent generating matrices, adaptive designs with less restrictions on the
generating matrix as a modification of our model should be considered for future
research.
Chapter 5
Asymptotic Properties of a Linear
Combination of Yn and Nn
5.1 Introduction
In the statistical studies of adaptive designs, some researchers build the central limit
theorem for a linear combination or linear transformation of the urn composition.
For example, using moments methods, Freedman (1965) showed the asymptotic
theorem of the urn composition for Bernard Friedman’s urn. Assume that the





where α, β are positive. It follows that Hi has a maximal eigenvalue λ1 = α + β
and the second largest eigenvalue λ2 = α − β. The asymptotic normality is given
in two cases:
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2 (Yn1 − Yn2) L→ N(0, λ22).
As for the GFU, Athreya and Karlin (1968) proved the limiting distribution
of the urn composition using the embedding theorem. Assume that E(d2ij) < ∞,
where dij is the (i, j)th element of the unique adding rule D. Let λi be any
eigenvalue other than the maximal one λ, with associated right eigenvector ξi.
























where c1 and c2 are some constants.
Athreya and Karlin’s model is seminal and influential to future research. Ex-
plicitly, it has a 2-folded importance (Rosenberger 2002). However, we believe that
it still has some room for improvement:
Firstly, in this model, the eigenvalues are all assumed to be simple. However,
in practice, it is common that the generating matrix is high dimensional and λi is
complex, which associates with multiplicity νi, where νi ≥ 1.
Secondly, no matter what the value of λi is, the expression of the variance
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terms is not available. Explicit expressions will be very useful in both research and
practice.
Last but not the least, the covariance terms between the eigenvectors belonging
to different eigenvalues are not studied, which also brings inconvenience to the
study.
Alternatively, in Bai and Hu (1999), the general form of the variance-covariance
matrix of Ynξi is given, where the generating matrices are nonhomogeneous and
the eigenvalues may be complex. However, in the case that τ , the greatest real
part of all the eigenvalues except 1, is equal to 1/2, in the variance-covariance
matrix, only the limiting point of the element with the highest order is given. The
reason is, when divided by n log2ν−1 n, all the other elements tend to 0, where ν is
to be defined later. However, the calculation is too rough to exhibit the accurate
formation of the matrix in question. Because each element in the matrix converges
to 0 at different rate.
In this chapter, in the background of adaptive designs, using a martingale ap-
proach, we present the limiting properties of a linear combination of the urn com-
position on ξ in the general case and give the exact expression of all the elements in
the variance-covariance matrix of both Ynξ and Nnξ. Moreover, by studying the
eigenstructure of the generating matrix, we propose the reason why the elements
in the variance-covariance matrices have different orders when τ = 1/2. The as-
ymptotic properties of RPW rule and GPU rule can be derived from the proposed
model easily.
This chapter is organized as follows: in Section 2, the model is formulated;
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the asymptotic properties of Ynξ are explored in Section 3; Section 4 focuses on
the limiting distribution of Nnξ; Some applications of the theoretical results are
proposed in Section 5; in Section 6, we provide some comments and conclusions.
5.2 Formulation of the Model
Similar to the model in Chapter 4, suppose that in an adaptive design, the main
objective is to compare the relative effectiveness of the K treatments while taking
ethical imperative into consideration, where K ≥ 2. Accordingly, there are K
types of balls in the urn representing the K treatments. Without loss of generality,
assume that, initially, there are u balls of each type, where u = 1/K. At stage i,
when a patient is available for randomization, a ball is randomly drawn from the
urn with replacement and the patient is assigned to treatment j according to the
type j of the ball obtained. When the response is observed, the urn composition
is adjusted by the adding rule Di, where the sum of each row is 1, i.e., the total
number of balls added each stage is 1. In addition, we assume that the generating
matrix is homogeneous, that is, E(Di|Fi−1) = H, where H is fixed.
By denoting the urn composition at the ith stage as Yi = (Yi,1, Yi,2, . . . , Yi,K),






, . . . ,
1
K
), an immediate result is
K∑
j=1
Yi,j = i+ 1.
Moreover, the selection state isXi = (0, 0, . . . , 1, . . . , 0), i.e., only the jth element is
1 if treatment j is selected at the ith stage, where i = 1, 2, 3, . . . , n, j = 1, 2, . . . , K.
To investigate the limiting distribution of Yn and Nn, intuitively, we know that
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the generating matrix H is crucial. Hence, we must study the eigen-structure of H
under the following assumption.
Assumption 5.1 Assume that H is irreducible with all the elements non-negative.
First, since H is nonnegative with the sum of each row 1, there exists a single
maximal eigenvalue λ1, where λ1 = 1, and a corresponding left eigenvector V,
whose elements are all nonnegative. For the convenience of calculation, we can
choose V, such that the sum of all the elements in V is 1.
Second, from the assumption and the knowledge in algebra, we can further show
that the elementary factors of the characteristic matrix of H, H− λI, are
(λ− 1), (λ− λ2)ν2 , (λ− λ3)ν3 , · · · , (λ− λs)νs,
where, as well as λ1, λi are also eigenvalues of H each with multiplicity νi for
i = 2, 3, . . . , s and
s∑
i=2
νi + 1 = K. Here, we assume that it is possible that λg = λh
for some g, h = 2, 3, . . . , s.
Therefore, we can define a matrix ξ = (ξ2, ξ3, · · · , ξs), where each block consists
of νi column vectors, i.e., ξi = (ξi1, ξi2, · · · , ξiνi). Here, the K-dimensional vector
space is cyclic relative to L = H−λiI, where {ξi1, ξi2, · · · , ξiνi} forms a cyclic basis,
where
ξi1 = Lξi2, ξi2 = Lξi3, . . . , ξiνi−1 = Lξiνi, ξiνi.
Substitute ξij into the expression of L, we obtain that
Hξi1 = λiξi1,
Hξi2 = λiξi2 + ξ1,
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...
Hξiνi = λiξiνi + ξiνi−1.
It means, in a block ξi, ξi1 is the right eigenvector of H with respect to λi.
Then, H has the following property:
H has a Jordan canonical form J, that is, T−1HT = J, where
J =

1 0 0 · · · 0 0
0 J2 0 · · · 0 0
· · · · · · · · · · · · · · · · · ·




λt 1 0 · · · 0
0 λt 1 · · · 0
· · · · · · · · · · · · · · ·
0 0 0 · · · λt

and T = (1′ ξ ) with 1 = ( 1 1 · · · 1 ).
5.3 Asymptotic Properties of Ynξ
5.3.1 Asymptotic Expectation
Under the rules described in Section 5.2, we have the following recursive relationship
Yn = Yn−1 +XnDn.
The conditional distribution of Xn is multinomial and E(Xn|Fn−1) = 1
n
Yn−1,
where Fi = σ(Y0,Y1,Y2, . . . ,Yi), i = 1, 2, 3, . . . , n, is a sequence of increasing
σ-fields.
Define {Qn = XnDn − E(XnDn|Fn−1)}, which is a sequence of bounded mar-
tingale difference with respect to {Fn}.
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Assumption 5.2 Assume that Dn and Xn are independent conditional on Fn−1.
From the above assumptions and notations, Yn can be represented recursively
as
















), Bn,n = I and I is an identity matrix.
Assumption 5.3 Assume that τ ≤ 1
2
, where τ is the second largest real part of
all the eigenvalues of H, i.e. τ = max
i=2,3,...,s
(Re(λi)).
What does this assumption imply? For example, in the two dimensional case,
if the generating matrix is given by p1 q1
q2 p2
 ,
this assumption is satisfied when p1−q2 ≤ 1
2
. In practice, it means that the number
of type 1 balls added upon a success of treatment 1 can not be much more than
the balls added upon the failure of treatment 2.
Under Assumptions 5.1-5.3, the order of the expectation of a linear transfor-
mation of Yn, Ynξ, is given in the following theorem:
CHAPTER 5. Asymptotics of a Linear Combination of Yn and Nn 145
Theorem 5.1 Using the notation defined above, as n→∞, we have
1√
n









In fact, based on the calculations in Chapter 2 - Chapter 4, the proof is similar
and straight-forward.
Since T−1HT equals a quasi-diagonal matrix J, for the convenience of calcula-
tion, we make a transformation on E(Ynξt).
Based on (5.1), we have
















= · · · · · ·






















(logh n)nλt(1 + o(1)),
where l = 1, 2, . . . , νt, h = 0, 1, . . . , νt − l.
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= (Y0ξt1 Y0ξt2 · · · Y0ξtνt )

O(nλt) O(nλt log n) · · · O(nλt logνt−1 n)
0 O(nλt) · · · O(nλt logνt−2 n)
· · · · · · · · · · · ·
0 0 · · · O(nλt)

= (O(nλt) O(nλt logn) · · · O(nλt logνt−1 n) ) .












The proof of Theorem 5.1 is complete.
5.3.2 Asymptotic normality
In this subsection, based on the results we have obtained so far, we further prove
the asymptotic normality of Ynξ. In the process of the proof, the following as-
sumption and preliminary results are necessary:
Assumption 5.4 Assume that E||E(Q∗nQn|Fn−1) − E(Q∗nQn)|| → 0 and Qˆn =
E(Q∗nQn)→ Qˆ as n→∞, where Qˆ is defined as the limiting point of E(Q∗nQn|Fn−1).
From the definition of Qn and Lemma 1.3, we can obtain the expression of Qˆ,
E(Q∗nQn|Fn−1)





where the (l, j)th element of D˜ is
K∑
i=1
viE(dildij|Fn−1) and E(XnDn|Fn−1) = VH.
Thus, this assumption is satisfied as long as Qˆn − Qˆ→ 0.
With the variance of Qn defined, we can move on to the asymptotic normality
of Ynξ, which is given by the following theorem:























) ) , (5.2)
















) in (5.2), the (l, k)th element
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where λ¯g is the conjugate of a complex number λg.
The further calculation is divided into the following two cases according to the
real part of λg or λh:






, or Re(λg) =
1
2



















l′!k′!(1− λ¯g − λh) [ξ
∗
gQˆξh](l−l′,k−k′),
where 1 ≤ l ≤ νg and 1 ≤ k ≤ νh.
(2) If Re(λg) =
1
2
and λg = λh for some g = 1, 2, . . . s, the (l, k)th element of
(5.3) is approximated by
n logl+k−1 n
(l − 1)!(k − 1)!(l + k − 1)[ξ
∗
gQˆξh](1,1).
Remark 5.1 In this case, for given g and h, the power of log n is l + k − 1, which
further corresponds to ξgl and ξhk in the cyclic space, i.e. the different layer of the
cyclical space defined by H and ξg and ξh.
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To show the asymptotic normality of YnξV
− 1
2
n is equivalent to verify the Lin-




Note that Yn − E(Yn) =
n∑
j=1
QjBn,j, which is the sum of a sequence of inde-
pendent martingale differences. From the fact that l and k are finite, we only need







































The last equation follows from the fact that Pr(QjBn,jV
− 1
2
n ≥ ε)→ 0.
By martingale central limit theorem, YnξV
− 1
2
n is asymptotic normal with mean
0 and variance-covariance matrix I.
The proof of Theorem 5.2 is complete.
5.4 Asymptotic Properties of Nnξ
5.4.1 Asymptotic Expectation
In the adaptive design described in the previous sections, Nn is defined as the total













Based on (5.5), we can derive some properties of Nn.





where V is defined in the last section.
Proof.








































Nn → V a.s. as n→∞.
The proof of Theorem 5.3. is complete.
Theorem 5.3 implies that as the number of patients recruited increases, the
proportion of patients assigned to each treatment will stabilize and tend to a vector
V.
As for the expectation of Nnξ, we have the following theorem:
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Theorem 5.4 The order of E(Nnξ) is controlled by
1√
n




































(I+ J) · · · (I+ J
i− 1)(T
−1ξt).































for some constants C1, C2 <∞ and  > 0 is small enough.
Hence, |ENn√
n
ξt| → 0 if Re(λt) < 1
2
.








Theorem 5.4 is proved.
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5.4.2 Asymptotic Normality






where Un is to be specified later and ξ is as defined in Section 5.2.
Proof.
Similar to the proof of Theorem 5.2, we need to define the asymptotic variance
of Nnξ first.
From the previous derivation, we know that as n→∞,


















= S1 + S2,
where Q˜j = QT and B˜i,j,− = (T−1Bi,jT)− has a quasi-diagonal Jordan form.
It follows that
var[(Nn − ENn)ξ] = var(S1) + cov(S1, S2) + cov(S2, S1) + var(S2).
In the sequel, we will find the four components respectively.
(I) From Theorem 5.1, it is straightforward that
E(Xi −Yi−1/i)∗(Xi −Yi−1/i)→ diag(V)−V∗V.
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(II) As for the second term,
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(III) Obviously, cov(S2, S1) is the complex conjugate of cov(S1, S2).
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where g, h are integers where g, h ∈ [2, . . . , s].




































































































































































































































(1− λ¯h)−(t′−l+1)(1− λ¯g − λh)−(s′+l+1).
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(1− λ¯h)−(t′−l+1)(1− λ¯g − λh)−(s′+l+1).
On the other hand, if Re(λg) =
1
2






































































s′ + t′ + 1
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s+ t− 1 .
With all the elements in the variance-covariance matrix given, we can define
Un = var[(Nn − ENn)ξ].
Remark 5.2 In the case that τ =
1
2
, in the variance-covariance matrix, each
element has a different order O(n logs+t−1 n), where the power of logn is s + t −
1, which further corresponds to ξgs and ξht in the cyclic space, i.e. the different
direction of the projection of ξg and ξh.
Coupled with Theorem 5.4, the asymptotic normality is quite straight-forward
from martingale central limit theorem.
The proof of the theorem is complete.
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5.5 Applications
1. RPW rule with τ =
1
2
. In the randomized play-the-winner rule, the adding
rule is given by Di =
 ηi 1− ηi
1− ηi ηi
, where ηi equals 1 or 0 according as
whether the ith patient’s response is either a success or a failure and define pj =
E(ηi| treatment j) and qj = 1 − pj, where j = 1, 2, then the generating matrix





Now, the eigenvalues of H are λ1 = 1 and λ2 = p1 + p2 − 1 each with multiplicity







From the preliminary results in Chapter 1 and theorems in this chapter, if
τ = λ2 =
1
2
, V = (2q2, 2q1), we have the following results:
Yn
n
→ V a.s. and Nn
n
→ V a.s.
Denote ξ as in the previous sections, then ξ = (1,−1)′ is the right eigenvector of
H with respect to λ2. Then,
E(Yn,1 −Yn,2)√
n logn
→ 0 and E(Nn,1 −Nn,2)√
n logn
→ 0.
The expression of Qˆ is given by
Qˆ =
 (p2 − q2)v2 −v1v2
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n ∼ N(0, 1)




n ∼ N(0, 1)
where Un = 8n logn.
2. GPU model with τ <
1
2
. In Wei (1979), generalized Po´lya urn model is applied in
the clinical trials as a generalization of the RPW rule. However, from the proposed
model, GPU can be derived easily and the asymptotic properties of both Yn and
Nn are obtained.






















The elementary factors of H − λI are (λ − 1) and (λ − 1
3




are eigenvalues with multiplicity 1 and 2 respectively.
Now, the basis of the cyclic space is {ξ21, ξ22}, where
Hξ21 = λ2ξ21,
Hξ22 = λ2ξ22 + ξ21.
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→ V and Nn
n
→ V,










From Theorem 5.1, we know,
EYn√
n
ξ → 0 and ENn√
n
ξ → 0.






where Vn = n
 v11 v12
v21 v22
 with v11 = 3[ξ∗Qˆξ](1,1), v12 = v21 = 3[ξ∗Qˆξ](1,1) +






The expression of Un is quite complex and is the sum of four terms,
Un = Un1 + Un2 + Un3 + Un4, where Un1 = n
 1 0
0 292.5




 and Un4 = n
 u11 u12
u21 u22
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3. GPU model with τ =
1
2






























 and the matrix

















Based on the theorems, we have the following results:
Yn
n






→ 0 and E(Nnξ)√
n log3 n
→ 0.
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5.6 Comments and Conclusions
In the previous sections, using a martingale approach, we established the limiting
theories of a linear transformation ofYn andNn on ξ, where ξ is a matrix consisting
of s blocks with each block containing the vectors in the basis of the cyclic space
relative to H − λgH for each eigenvalue λg. This is more general than Athreya’s
model. Moreover, the form of the variance-covariance matrix is given in the exact
expression.




orders of the elements in the variance-covariance matrices of both Ynξ and Nnξ




some g and λg = λh, we learn that the orders of the elements in the (g, h)th block
of the variance-covariance matrix differ from each position ( both row and column).
Explicitly, for both Ynξ and Nnξ, the order is O(n log
s+t−1 n), where (s, t) is the
coordinate of the it in the block. It shows that the variance terms have different
rate of convergence in this case. In fact, the different orders reflect the projection
of the vectors in ξ to different directions, which shows different rate of convergence.
Unfortunately, in Athreya’s model, only the smallest variance is considered, i.e.,




otherwise. It is the variance of a linear combination of Yn on a right eigenvector
of H. However, as for the other vectors in the basis of the cyclic space with higher
orders, the investigation is ignored. On the other hand, in Bai and Hu (1999), as
contrast to Athreya’s model, only the worst situation is considered, i.e., the largest
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variance. In his paper, the limiting point of the element on the right lower corner in
the variance-covariance matrix is shown, which converges at the rate O(n log2ν−1 n).
Under this rate, the remaining elements all tend to 0.
In the proposed paper, by the thorough investigation of each element in the
variance-covariance matrices Un and Vn, we can show the subtle differences among
the covariance terms. Furthermore, when the eigenstructure of H is studied, the
structure of the variance is clearer and reflects the small but vital distinction among
different terms. And the results in the proposed paper have theoretical importance
in the study of adaptive designs.
Chapter 6
Future Research
In Chapter 2 to Chapter 5, we proposed some new adaptive designs and addressed
the asymptotic properties. However, in the process of my research, I still find some
interesting topics which are not covered or solved in the thesis. Therefore, follow
up research is strongly recommended in the following fields.
First, in the proposed designs, we assume that τ is not greater than 1/2. How-
ever, in practice, due to the complexity of clinical trials, a variety of generating
matrices may be used, which may require the distribution of Yn when τ > 1/2.
Although the urn composition will converge as well no matter what τ is, when






)2λ2 will diverge. In fact, in Freedman (1965), the problem is partially solved,
i.e., n−τ (Yn,1−Yn,2) converges almost surely to a random variableW whose distrib-
ution function is unknown. In the model, Yn
 1
−1
 is normalized by nτ . However,
the distribution function of W is not given. The investigation of asymptotics of
adaptive designs in this case is suggested.
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Secondly, in Chapter 2 and Chapter 3, we assume that the patient’s time to
response or the time that the response is missing from the trial is independent of the
treatment assignment and the response generated. However, in some trials, if this
assumption is violated, the expected number of balls added upon the occurrence
of each response may differ according to the treatment allocation. Thus, the row
sum of the generating matrix is not constant. If this is true, lemma 1.1 will not
hold. Whether the asymptotic normality still holds in this case is an important
and useful topic for further research.
Thirdly, in Chapter 3, we assume that the patient’s response occurs within M
stages, where M is a finite constant. Based on this assumption, a natural consid-




Pr(t = i) converges to 0 at certain rate, the asymptotic normality can
also be established.
Another point is, in Chapter 5, we have investigated the asymptotic properties
of a non-convergent model. Although the results are helpful in clinical trials be-
cause it allows flexibility of the generating matrices while does affect the efficiency
for making inference, there are still some limitations in the model. For example,
when we make the assumptions, some restrictions are imposed on the generating
matrices to make them converge under some arithmetic operations, which limits
the usefulness of the model. Since, in practice, if the generating matrices have a
time trend or depend on some divergent covariates, they will not converge in any
format. In this sense, the usefulness of the model is limited. But, due to the prac-
tical importance of the adaptive designs with nonconvergent generating matrices,
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nonconvergent models with less restrictions as a modification of our models should
be considered for future research. For example, based on the results in the thesis,
we can extend easily to adaptive designs where the K-step weighted mean of the
generating matrices is constant or the generating matrices have a time trend. In
addition, the patient allocation under nonconvergent generating matrices is also of
interest. A thorough study of urn models with more diversified generating matrices
should be considered.
In addition, in the design of trials, the adding rules should not only depend on
the outcome of the previous trial, it should also depend on the current cumulative
results. A case where the adding rule id dependent on the relative success rates of
the K competing treatments is considered in Bai et al (2001). Their results can be
further generalized to cases that the adding rules are general functions of current
successes rates at that stage. However, the problem that the adding rules are
functions of the urn composition is still open. Whether the asymptotic properties
still hold in this case is an important question in the future research.
Appendix
In the appendix, we list the S-plus programs for reference.











y1_matrix(0,n1,n2) #number of type 1 balls
y2_matrix(0,n1,n2) #number of type 1 balls
Nn1_matrix(0,n1,n2) #number of patients in treatment 1
Nn2_matrix(0,n1,n2) #number of patients in treatment 2
Time_matrix(0,n1,n2) #time to response











for ( i in 1:n1){
y1[i,1]_1/2
y2[i,1]_1/2
for ( j in 2:n2){
r1_runif(1)
r11_runif(1)







































































































2. Program for the simulation of adaptive design with two different
generating matrices





n1 <- 5000 #repeat n1 times at each stage
n2 <- 1000 #n2 stages
h <- seq(1,n2)
urn.whiteno <- matrix(0, n1, n2)

























H <- matrix(0, 2, 2)






#part 1: asymptotic expectation
for(i in 1:n1) {
r <- runif(1)
r1 <- runif(1)
if(r <= 0.5) {
if(r1 <= p1)
urn.whiteno[i, 1] <- 0.5 + a11




urn.whiteno[i, 1] <- 0.5 + a12
else urn.whiteno[i, 1] <- 0.5 + b12
}
for(j in 2:n2) {
r2 <- runif(1)
r3 <- runif(1)
if((j/2) == trunc(j/2)) {
if(r2 < (urn.whiteno[i, j - 1]/j)) {
if(r3 <= p1)
urn.whiteno[i, j] <- urn.whiteno[i, j - 1] + c11




urn.whiteno[i, j] <- urn.whiteno[i, j - 1] + c12




if(r2 <= (urn.whiteno[i, j - 1]/j)) {
if(r3 <= p1)
urn.whiteno[i, j] <- urn.whiteno[i, j - 1] + a11





urn.whiteno[i, j] <- urn.whiteno[i, j - 1] + a12






urn.expectation <- apply(urn.whiteno, 2, mean)/(h+1)
tsplot(urn.expectation, xlab = "estimate of the mean of Yn,1")
lines(rep(eigenvector.H[1] ,n2))
urn.variance <- rep(0, n2)
if ( abs(eigenvalue.H2-0.5)<1e-8 ){
urn.variance <- (apply(urn.whiteno, 2, var))/( (h/2) *log(h/2) )
}
else{
urn.variance <- (apply(urn.whiteno, 2, var))* (2-4*eigenvalue.H2)/h
}
tsplot(urn.variance, type="pl",pch=".",xlab="estimate of Var(Yn,1)/Un^2")
lines(rep(0.0408,n2))
res1_(urn.whiteno[ ,n2]-rep(eigenvector.H[1],n1))/0.0408
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